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Multiple signaling pathways control every aspect of cell behavior, organ formation, and 
tissue homeostasis throughout the lifespan of any individual. This review takes an onto-
genetic view focused on the large superfamily of TGF-β/bone morphogenetic protein 
ligands to address thymus morphogenesis and function in T cell differentiation. Recent 
findings on a role of GDF11 for reversing aging-related phenotypes are also discussed.
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introduction
The adaptive immune system evolved as a complex set of defense mechanisms amplified by the speci-
ficity properties of antigen receptor-bearing B and T lymphocytes (1). Following blood trafficking 
into the thymus, bone marrow-derived lymphoid progenitors become committed to T cell lineage 
development. Within this organ, cell specialization occurs gradually in a manner that T cell develop-
ment results in the generation of conventional CD4 and CD8 αβ T cells along with natural killer T 
cell (NKT; an innate-like T cell subpopulation), regulatory T cell (Treg), and γδ T cell subsets (2). 
Classically, commitment to T cell lineage was found to rely on the Delta-class Notch ligand Delta-like 
4 (DLL4) and the interleukin-7 (IL-7) along with kit and flt3 ligands at stages usually prior to TCRβ 
chain assembling (3–6). Branching into distinct paths can be observed throughout the mainstream 
developmental pathway, from the double-negative (DN; CD4−CD8−) T cell precursors to the highly 
expanded double-positive (DP; CD4+CD8+) cells, and the resulting mature single-positive (SP; 
CD4+CD8− or CD4−CD8+) stages. Thus, at specific niches, the thymus provides to developing T cells 
signals that trigger a series of ordered events leading to cell proliferation, TCR gene rearrangements, 
and selective checkpoints along with massive cell death (7). Altogether, these events culminate in 
a proper repertoire of distinct and specialized mature thymocyte subpopulations able to emigrate 
to the periphery. In this review paper, we highlight the role of members of the large transforming 
growth factor-β (TGF-β) superfamily (Box 1) during thymic ontogeny, thymic epithelial cell (TEC) 
differentiation and function, as well as T cell maturation. Lastly, we discuss recent information on a 
possible regenerative potential of TGF-β ligands to rescue aging-related thymus atrophy.
TGF-β Signaling and Thymus Formation
Organogenesis relies on well-organized interactions between distinct germ layers and differentiating 
cell types controlled by intricate molecular hierarchies. Thymus development occurs from common 
parathyroid bilateral rudiments in the epithelial endodermal lining of the third pharyngeal pouch 
around embryonic days (E) 9.0–9.5 in mice and early week 5 in humans (Figure 2A) (41–44). As 
growth continues through E10.5 in mice and early week 6 in humans, the contact between the third 
pharyngeal pouch and the third pharyngeal cleft ectoderm determines paired organ primordia with 
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stratified epithelium and a central lumen lined by precursors of 
medullary thymic epithelial cells (mTECs). These cells are char-
acterized by the expression of both claudin-3/4 and cytokeratin-5 
(K5) (46, 47). Further development of thymic medulla also 
depends on the successful establishment of the cortical region, as 
observed in mice with arrested T cell development (48). Within 
each primordium, a dorso-rostralmost domain expressing Gcm2 
gives rise to a parathyroid gland from E9.5 in mice or as early 
as the onset of week 6 in humans, whereas a ventro-caudalmost 
domain identified by Foxn1 expression produces a thymic lobe 
from E11.25 in mice or mid-week 6 in humans (Figure 2B) (44, 
49–52). Epithelial cell proliferation fills the pharyngeal pouch 
lumen by forming cord-like structures with smaller lumina, 
similar to branching morphogenetic events in other organs 
(Figure  2C) (47). In this context, activation of Foxn1 blocks 
the respiratory development (53) and, along with subsequent 
colonization by lymphocyte precursors, seems to be responsible 
to produce a concentric medulla less densely cellular than the sur-
rounding cortex (47). Fetal liver-derived lymphocyte progenitors 
colonize the embryonic thymus from E11.5 in mice and week 8 
in humans (54, 55), whereas short-term apoptotic events around 
E12.0 disconnect the developing anlagen from the embryonic 
pharynx (41). The rudiments migrate downwards at different 
paces, gradually resolving the Gcm2- and Foxn1-restricted 
domains into two morphologically distinct structures enclosed 
by neural crest-derived mesenchyme (Figures  2C–F) (51, 56). 
Parathyroid primordia usually lag behind and move toward the 
tracheal region dorsally to the thyroid gland, whereas thymic 
rudiments move ventrally and more caudally into the thoracic 
cavity (Figures 2D,E). The thymic primordia ultimately fuse at 
the midline to produce a bi-lobed organ above the developing 
heart (Figure 2F). Unlike mice, humans exhibit superior parathy-
roid glands derived from the fourth pharyngeal pouch (Figure 2) 
(43), whereas organogenesis of the human thymus is essentially 
similar to mice both morphologically and molecularly (44). Each 
of these morphogenetic events during thymus organogenesis is 
controlled by a multitude of signals, including members of the 
TGF-β superfamily.
Thymus Specification and Thymic epithelial 
Cell Differentiation
Early production of Bmp4 by the endoderm, the surrounding 
neural crest-derived mesenchyme, and the overlying ectoderm of 
the third pharyngeal arch and cleft raised the possibility that bone 
morphogenetic protein (BMP) signals may trigger thymus and 
parathyroid formation (57). However, conditional inactivation 
of Bmp4 in both pharyngeal endoderm and mesenchyme using 
a Foxg1–Cre line had no effect in organ induction, but resulted 
in abnormal morphogenesis (see below) (58). This could be the 
result of a short-time window of 24 h necessary to establish the 
prospective thymic and parathyroid domains as observed in 
chicken embryos (59). Indeed, Patel et  al. have observed using 
a Bmp4lacZ-reporter line that the onset of Bmp4 production 
occurred at E9.5 in the ventral pharynx close to the third pouch 
entrance, but not in the pouch endoderm or mesenchyme proper 
(57). Expression in these tissues was later achieved and expanded 
to the overlying ectoderm (57). The realization that endoderm 
patterning occurs before primitive gut and pharyngeal pouch 
formation still hampers the identification of signals responsible 
for thymus specification in vivo and other members of the TGF-β 
superfamily may also be at play (60). Particularly, activin A is 
BOX 1 | Multiple roads for signaling by TGF-β superfamily members.
The TGF-β superfamily comprises TGF-β1–3, bone morphogenetic proteins 
(BMPs), growth and differentiation factors (GDFs), Nodal, activins/inhibins, 
Müllerian inhibiting substance (MIS)/anti-Müllerian hormone (AMH), and Lefty. 
These ligands were initially grouped accordingly to the functional roles obser-
ved following their original identification (8–11). As it became clear that most 
ligands play multiple functions depending on cell type, developmental stage, 
or tissue conditions, they are now classified by sequence similarity and the 
downstream pathway they activate (12). Each family member has an overall 
basic structure, in which inactive forms are produced with an N-terminal 
secretion peptide and a large propeptide domain known as latency-associated 
peptide (LAP). Cleavage of the propeptide domain by proprotein convertases 
releases a mature domain at the C-terminus, which eventually dimerizes (13). 
The propeptide domain has major regulatory roles. It influences protein stability 
and functions as chaperone during secretion, also mediating diffusion through 
interactions with the extracellular matrix and inhibiting the active peptide form 
even after cleavage (14–16).
Signaling by TGF-β superfamily members occurs through a similar 
mechanism, but operates with distinct components. Ligands bind single-pass 
transmembrane receptor serine/threonine kinases, which relay the signal for 
intracellular effectors capable of translocating into the nucleus to modulate 
gene transcription (Figure 1). More specifically, these receptors are classified 
into two structurally similar types. Ligand binding occurs only through type II 
receptors, which then recruit and phosphorylate type I receptors [e.g., Ref. (17, 
18)]. Type II receptors, such as ActRII (Acvr2a) or ActRIIB (Acvr2b), may take 
part in many distinct pathways or may be specific for a given group of ligands, 
such as AMHR2 (Amhr2) for MIS/AMH, BMPRII (Bmpr2) for most BMPs and 
Gdf9, and TβRII (Tgfbr2) for TGF-βs (19, 20). Type I receptors are also known 
as activin receptor-like kinases (ALKs) due to their sequence similarity to acti-
vin receptors (21). These receptors are usually specific to a more restricted set 
of ligands. For instance, Nodal, Gdf1, Gdf11, activins, and inhibins bind ActRII 
to recruit Alk4 (Acvr1b) and Alk7 (Acvr1c) or they bind ActRIIB to recruit either 
Alk4, Alk7, or Alk5 (Tgfbr1) (19). Together, type II and type I receptors form a 
heterotetrameric complex, in which the type I receptor further phosphorylates 
intracellular effectors of the Smad family (22). Depending on the ligand/recep-
tor complex they are responding to, receptor-activated Smads (R-Smads) can 
be subdivided into two groups: a BMP-related set gathers Smad1, Smad5, 
and Smad9 (formerly Smad8), whereas Smad2 and Smad3 are responsive 
to TGF-β-related signals (Figure  1). An N-terminal MH1 domain negatively 
regulates the MH2 domain, being indispensable for Smad translocation into 
the nucleus and DNA binding (23–25). However, these functional properties 
do not hold true for all R-Smads. In particular, Smad2 seems to interact to 
DNA only indirectly (24).
A common mediator Smad (co-Smad), or Smad4, integrates signals 
from both branches by associating with the R-Smads (Figure 1). They form 
transcriptional complexes able to translocate into the nucleus (26–28). Nuclear 
transportation of Smads depends on accessory proteins, particularly importins, 
exportins, and nucleoporins (29, 30). The presence of DNA molecules harbo-
ring Smad-binding elements favors heterodimerization between R-Smads and 
co-Smad (28). They ultimately associate with cell-type-specific transcription 
factors and co-activators to regulate a plethora of target genes (31).
Regulation of Smad activity occurs through multiple mechanisms (32). Two 
inhibitory Smads (I-Smads) impair signaling by competing with R-Smads for 
receptors or by co-Smad interaction (33). For instance, Smad6 forms stable 
interactions with type I receptors, blocking phosphorylation of Smad2 and 
Smad1, but not Smad3 (34, 35). Similarly, Smad7, the other I-Smad mem-
ber, also binds type I receptors and suppresses further phosphorylation by 
targeting them for proteasome-dependent degradation (35, 36). The available 
literature on the molecular interactions of TGF-β superfamily members is vast, 
but not in the scope of this review. Further information can be found elsewhere 
(33, 37–40).
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required to induce definitive endoderm prior to the differentia-
tion of third pharyngeal pouch endoderm in vitro (61). Since gene 
targeting of some superfamily ligands or their receptors results in 
embryonic lethality (62–64), new conditional mutants should be 
produced taking into consideration that gene deletion may have 
to occur earlier and at different embryonic compartments than 
previously thought.
The possibility that thymus induction depends on synergistic 
effects of TGF-β superfamily ligands with non-superfamily 
signals is a likely case (59). Endoderm-derived undifferentiated 
epithelial cells comprise a homogeneous population pheno-
typically defined as cytokeratin (K)5+K8+EpCAM+MTS24+ in 
the thymic primordium of mouse embryos at E12.0 (65). When 
a single progenitor cell labeled with enhanced yellow fluorescent 
protein (eYFP) was microinjected into an unlabeled syngeneic 
thymus rudiment with the same age, and transplanted under the 
kidney capsule, both cortical and medullary portions showed 
scattered eYFP+ TECs also positive for region-specific markers 
after 4  weeks, revealing that common bipotent progenitors are 
able to produce both epithelial lineages during embryogenesis 
(65). Recently, thymic epithelial progenitor cells (TEPCs) bearing 
stem-cell features were also identified in the thymus of adult mice 
as a MHCIIlowα6 integrinhighSca-1high subset (66). They mature in a 
highly complex stepwise process not fully understood, ultimately 
producing cortical TECs (cTECs) or mTECs (67).
Cortical TECs are sparsely distributed and may be identi-
fied as CD45−EpCAM+Ly51(CD249)+Ulex europaeus lectin 1 
(UEA-1)−K5−K8+ cells with high levels of both MHC II and the 
proteasome subunit β5t (68–71). Considering the TGF-β-related 
pathways, cells from neonatal mice express both the Acvr2a 
(ActRII) and Acvr2b (ActRIIB) genes for the common receptors, 
in addition to Acvr1 (Alk2), Bmpr1a (Alk3), and Bmpr2 (BMPRII) 
FiGURe 1 | Signaling by ligands of the TGF-β superfamily in the thymus. 
Members of the TGF-β superfamily may signal by either the TGF-β (reddish) or 
the BMP branch (bluish). Upon binding to type II serine/threonine receptors 
occurs the recruitment of type I receptors, which further phosphorylate Smad 
proteins. Whereas ActRIIA and ActRIIB may be shared between both 
pathways, TβRII and BMPRII are specific to TGF-β and BMP signaling, 
respectively. In general, Smad2 and Smad3 relay signals from the Alk4, Alk5, 
and Alk7 receptors, while Smad1, Smad5, and Smad8/9 are phosphorylated 
by Alk2, Alk3, and Alk6 receptors. However, Alk2, Alk6, and Alk7 are not 
expressed during thymocyte maturation. Modulation of gene expression occurs 
after Smad complex translocates into the nucleus and depends on the 
interaction with additional protein complexes (not shown).
for the BMP-specific receptors, and the TGF-β-specific type I 
receptors, Alk4 (Acvr1b) and Alk5 (Tgfbr1), and type II receptor 
TβRII (Tgfbr2) (71, 72). This set of receptor genes allows cTEC 
to respond to both signaling branches of the TGF-β superfamily, 
even though the BMP receptor, Bmpr1b (Alk6), and the TGF-β 
receptor, Acvr1c (Alk7), are not present. Yet, expression of subunit 
genes Inha and Inhbb for inhibins and activins, Bmp2 and Bmp4, 
and Tgfb1 and Tgfb3 makes possible the existence of an autocrine 
circuitry for thymic homeostasis, and indicate that these factors 
might influence early thymopoiesis (71, 72).
In the thymic medulla, mTECs are characterized by a 
CD45−EpCAM+Ly51−K5+K8− phenotype with variable levels of 
UEA-1, MHCII, CD80, and Aire (67). These distinct expression 
profiles seem to take part in the differentiation program in which 
MHCIIhighCD80high mature mTECs expressing Aire are respon-
sible for the production of numerous peripheral self-antigens 
in the thymus, a critical event for central tolerance (67, 73–77). 
Hence, SP cells that strongly interact with self peptides through 
MHC molecules (pMHC) arrest migration, exhibit sustained 
TCR activation, persistent high levels of cytosolic Ca2+, and early 
caspase activation, leading to macrophage-dependent phago-
cytosis (78, 79). Surprisingly, thymocyte apoptosis triggers the 
production of all three TGF-β ligands by dendritic cells (DC), 
macrophages, and TECs in the medullary region of neonate or 
adult thymuses, a phenotype that was partially impaired in Bim 
mutants (80). In addition, apoptosis-driven production of TGF-β 
signals resulted in an increased generation of thymic regulatory 
T (tTreg) cells (see below) (80). Interestingly, mTECs are the cell 
type in the thymus that express most ligand genes of the TGF-β 
superfamily and their cognate receptors – Inha and Inhbb, Bmp2, 
Bmp3, Bmp4, Bmp5, Bmp6, and Gdf6/Bmp13, Gdf3, Gdf6/Bmp13, 
Gdf8/myostatin, Gdf10, Gdf11, and Gdf15, Lefty1 and Lefty2, 
FiGURe 2 | Signaling by TGF-β superfamily members during thymus 
organogenesis. Schematic representation of thymus formation at different 
stages of development. (A–C) Thymus specification viewed dorsally at the 
ventral half of the pharyngeal region. (A) The common parathyroid–thymus 
primordium arises from the third pharyngeal pouch endoderm. (B) Within each 
anlage, mTEC precursors line a central lumen surrounded by a dorso-
rostralmost domain expressing the BMP-antagonist Noggin and the 
parathyroid specific gene Gcm2 (light green), whereas the ventro-caudalmost 
domain expresses Bmp4 and the thymus-specific gene Foxn1 (blue). (C) Each 
primordium grows in size while proliferating cells fill the rudiment lumen, later 
colonized by lymphocyte precursors to produce an inner medulla. (D–F) 
Thymus migration toward the heart. The inferior parathyroid (light green) and 
the thymus (blue) primordia are gradually resolved as they migrate downwards. 
(D) TGF-β cues from the endothelium of pharyngeal blood vessels (e.g., carotid 
arteries) seem to orient thymic and parathyroid migration toward their final 
location. (e) The third pharyngeal pouch-derived thymic and the inferior 
parathyroid rudiments pass by the primordia of the superior parathyroid (dark 
green), which migrate only a short distance downward the tracheal region. (F) 
Fusion of the thymic primordia occurs at the midline just above the developing 
heart (not shown) [modified from Ref. (45)].
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Tgfb1, Tgfb2, and Tgfb3 along with Acvr2a (ActRII), and Acvr2b 
(ActRIIB), Acvr1 (Alk2), Bmpr1a (Alk3), and Bmpr2 (BMPRII) 
for BMP/growth and differentiation factor (GDF) signaling, and 
Acvr1b (Alk4) and Tgfbr1 (Alk5) for the TGF-β/Activin/Nodal 
pathway, in addition to the type III receptor gene Tdgf1 (Cripto) 
(71, 72, 81, 82).
The possibility that members of the TGF-β superfamily 
produced by mTECs may influence T cell differentiation or 
impact thymus physiology cannot be ruled out and remains to 
be thoroughly investigated. For instance, despite the previously 
identified BMP ligands in mTECs  –  Bmp3/osteogenin, Bmp5, 
Bmp6, and Bmp13 – there is no available functional information 
regarding their activities in the thymus to our knowledge. It is 
known, on the other hand, that Bmp6 exerts an antiprolifera-
tive effect in peripheral CD19+ B cells and induces apoptosis in 
CD27+ memory B cells (83). By contrast, Tgfbr2 deficiency in 
differentiating T cells increased apoptosis of TCRβhighCD4+ and 
TCRβhighCD8+ mature SP cells after anti-CD3 treatment or of 
TCRβhighOT-II T cells after antigen-dependent stimulation, thus 
revealing that TGF-β signals might be involved in thymocyte-
negative selection (84). Interestingly, loss of Tgfbr2 in TECs using 
a Foxn1–Cre mouse line resulted in an expansion of the mTEC 
compartment  –  especially MHCIIhigh cells  –  without affecting 
cTEC cellularity and the morphology of the corticomedullary 
junction (85). Indeed, other lymphocyte-derived signals than 
TGF-β ligands are known to influence mTEC maturation, a 
phenomenon that is largely known as “thymic cross-talk” (86).
Signaling by TGF-β superfamily members appears to play a 
secondary role in regulating a master regulator of thymus devel-
opment and function. Inactivation of the transcription factor 
Foxn1 results in an athymic phenotype despite the formation of 
an epithelial anlagen during embryogenesis (49, 87). Expression 
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of Foxn1 in thymic primordia is anticipated by the production 
of Bmp4 and Wnt4 in the epithelium and the adjacent mesen-
chyme of the third pharyngeal pouch from E10.5 in mice and 
from mid-week 6 in human embryos (23, 57, 88). Accordingly, 
in  vitro treatment of fetal thymic organ culture (FTOC) with 
BMP4 or overexpression of Wnt4 in a TEC cell line upregulated 
the expression of Foxn1 (88, 89). However, conditional inactiva-
tion of Bmp4 in the pharyngeal endoderm and mesenchyme 
did not affect Foxn1 expression (58), similarly to transgenic 
embryos expressing the BMP-antagonist Noggin in TECs (90). 
In turn, information on blockage of Wnt4 and its effect over the 
expression of Foxn1 is limited. In particular, Talaber et al. have 
shown that a single administration of dexamethasone caused 
the reduction of both Wnt4 and Foxn1 levels (91). Interestingly, 
conditional deletion of β-catenin in mTECs using a BK5–CreERT 
line resulted in Foxn1 downregulation (92). Altogether, the avail-
able evidence suggests that induction or maintenance of such an 
essential transcription factor in the thymic epithelia relies on an 
intricate molecular hierarchy with a key participation for BMP 
and WNT signals, which may provide some kind of redundancy 
for TEC differentiation and function.
With a great potential for translational medicine, differen-
tiation of TEPCs from mouse or human embryonic stem cells 
(ESCs) can be achieved under culture conditions by the addition 
of selected growth factors, including TGF-β superfamily ligands. 
For instance, Lai and Jin have initially reported that incubation 
with Fgf7, Bmp4, Egf, and Fgf10 produced K5+K8+EpCAM+ 
cells from mouse ESCs (93). These cells were able to further 
differentiate into medullary K5+K8− and cortical K5−K8+ TECs 
when transplanted with CD4−CD8−CD45+ thymocytes under 
the kidney capsule and sustain normal T cell maturation (93). In 
humans, an Activin A-dependent inductive stepwise process first 
differentiate ESCs into definitive endoderm (94), and later into 
SOX2+FOXA2+CDX2− anterior foregut endodermal cells by the 
concurrent inhibition of BMP and Activin/TGF-β signaling using 
Noggin and the type I receptor-specific inhibitor SB-431542, 
respectively (95). Further development into TEPC may be 
achieved by relatively similar approaches, generally modulating 
retinoic acid, canonical Wnt, and BMP level (61, 96).
Thymus Colonization by Lymphoid Precursors
Colonization of the thymic primordia occurs through intermit-
tent cell flow based on chemokine-dependent mechanisms (55, 
97–100). It begins discretely prior to organ vascularization 
with T cell-restricted progenitors that are unable to definitely 
populate the thymus (55, 97). Cell influx is transiently inter-
rupted during thymus migration to the thoracic cavity (42). 
Then, a second wave of cell colonization brings multipotent 
T cell- and NK-cell progenitors before birth (55). The most 
significant chemokines currently identified for attracting early 
T lineage progenitors (ETPs) to the developing avascularized 
thymus are CCL25 and CCL21 (98). Curiously, whereas CCL25 
is produced by both Foxn1-positive TECs and the adjacent 
parathyroid primordium, CCL21 is expressed only by Gcm2-
positive cells (99, 101). These ligands signal, respectively, 
through the CCR9 and CCR7 receptors present in CD45+ ETPs 
(102–105). However, it is still poor defined whether members 
of the TGF-β superfamily directly or indirectly influence or are 
modulated by these chemokines during thymus colonization. 
In particular, Gordon et al. observed delayed ETP homing into 
Bmp4-deficient thymic primordia at E11.5, but no significant 
differences in CCL25 expression in relation to wild-type thymus 
(58). The relationship with CCL21, other chemokines and their 
cognate receptors in the embryonic thymus, if present, remains 
to be determined. Of note, many pathological conditions and 
morphogenetic events show participation of TGF-βs, BMPs/
GDFs, and activins/inhibins in the modulation of chemokine 
production and vice versa (106–113).
Interaction of immigrating lymphocyte progenitors with 
the thymic stroma is critical for adult thymus organization, 
but not for TEC differentiation during embryonic develop-
ment. Using CD3ϵ transgenic mouse embryos, known to 
exhibit arrested T cell maturation at the triple negative (TN) 
CD3−CD4−CD8−CD44+CD25− ETP stage (114, 115), Jenkinson 
et al. have shown that K5+K8+ bipotent TEPCs normally differ-
entiate into functional K5+K8− medullary and K5−K8+ cortical 
TECs, although adult thymus in these transgenic animals exhibit 
persistent flat organization with morphologically abnormal 
cortex (115, 116). In particular, transfer of normal bone marrow 
cells into RAG2−/−; tgϵ26 chimeric mice, in which bone marrow 
cells from mice mutant for the recombination activating gene 2 
(RAG2) were previously transplanted into newborn tgϵ26 mice, 
rescued thymic organization and cellularity in the adult (48).
Thymus Migration
The subsequent migration of the thymus into the thoracic cavity 
also relies on signaling by members of the TGF-β superfamily 
and depends on neural crest cells. Despite a minor contribution 
in thymus cellularity, forced production of the BMP-antagonist 
Noggin in the caudal hindbrain prior to neural crest migration 
using B2-NC:Noggin transgenic mice culminated in thymic 
hypoplasia or aplasia later in development (117). Indeed, Bmp2 
induces Cdc42-dependent actin cytoskeleton reorganization and 
filopodia formation in neural crest cells, consequently affecting 
their subsequent migration (118). Moreover, conditional loss 
of Bmp4 in mice expressing Foxg1–Cre impaired the separation 
between correctly patterned parathyroid and thymus, which also 
exhibited a partially compromised capsule (58). Yet, based on 
observations performed for thyroid migration (119), Gordon 
and Manley have proposed that the downward migration of the 
thymus may be driven by signals from the pharyngeal blood 
vessels, more specifically the carotid arteries (Figures  2D–F) 
(42). Remarkably, mouse embryos with cardiac neural crest cells 
deficient for the type I receptor Alk5 (Tgfbr1) show defective 
cardiac outflow development, with atypical branching of carotid 
arteries and failed migration of still connected parathyroid and 
capsule-encased thymus (120). This raises the possibility that the 
directional cue for thymus migration might be Alk5 ligand (e.g., 
TGF-β1–3 or Gdf11), possibly secreted or released through the 
endothelium (Figures 2D–F). By contrast, conditional inactiva-
tion of Tgfbr2 in TECs by a Foxn1–Cre mouse line does not affect 
thymus final positioning (121). Although producing distinct 
phenotypes, each signaling branch by members of the TGF-β 
superfamily is involved in the downward migration of thymic 
FiGURe 3 | TGF-β superfamily during thymopoiesis. Levels of selected 
ligands, receptors, and Smad intracellular effectors during the differentiation of 
αβ T lymphocytes. Common receptors between the TGF-β and the BMP 
branches are colored in shades of gray, whereas components of the BMP and 
the TGF-β pathways are colored in shades of blue and red, respectively. The 
darker orange region of the scheme represents the thymic cortex, whereas 
light orange represents the thymic medulla. A thin corticomedullary region is 
represented in between the cortex and medulla. Omitted components are 
either not present during thymocyte maturation or no information is available at 
present. DN, double-negative; DP, double-positive; SP, single-positive.
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primordia and reveals a critical, but still poorly understood role 
for the neural crest-derived capsule during thymus organogen-
esis. Neural crest cells may also differentiate into endothelial cells, 
pericytes, and smooth muscle cells, and were found to persist in 
adult mice up to the onset of thymus involution (122).
Thymus Organization and Maturation of 
T Cells Under TGF-β Superfamily Signals
The adult thymus exhibits two gross anatomical regions easily 
identified by their histological staining patterns. The peripheral 
cortex harbors more immature and mostly small thymocytes, and 
is darker-stained due to a higher cell density. A corticomedul-
lary junction supplied by numerous septal blood vessels makes 
the transition between the cortex and the central medulla. This 
latter region is paler due to cell size and a lower T cell density 
(123–125). A capsule of connective tissue encases the organ. It 
consists of an outer layer rich in type I collagen and an inner 
layer of reticular fibers containing type III collagen, and projects 
type I collagen-containing septa into the parenchyma, partially 
subdividing the thymus into smaller lobules (126).
Signals from members of the TGF-β superfamily have a major 
influence on T cell differentiation and thymus homeostasis. As 
secreted molecules, they may be locally produced by thymic 
stromal cells and act over developing T cells as paracrine factors 
or be produced by the thymocytes themselves and work auto-
crinely. Alternatively, factors from the developing T cells may 
similarly operate over stromal cells to support thymus homeo-
stasis. However, thymocytes do not express most members of the 
TGF-β superfamily and the ones present vary in expression as 
cells differentiate (Figure 3). Similar changes are also found for 
receptor genes (127). Such differences in gene expression occur 
during T cell maturation, but also when comparing the same 
stage from fetal and adult thymuses (127–131). Nevertheless, pro-
vision of soluble growth factors seems to rely mostly to stromal 
cells, particularly TECs (71, 127). It is still possible that members 
of the TGF-β superfamily also act over large distances, being 
produced by other organs and reaching the thymus through the 
circulatory system (132). The importance of endocrine stimuli for 
intrathymic T cell maturation has been largely investigated (133), 
but whether a given TGF-β ligand exerts long-range effects over 
thymopoiesis remains to be properly addressed.
Changes in phosphorylation levels of Smad2/3 (pSmad2/3) 
and Smad1/5/8 (pSmad1/5/8), respectively, used as read-outs for 
the activities of TGF-β/Activin/Nodal and BMP/GDF signaling, 
follow differences in the expression of respective cognate recep-
tors as thymocytes mature (134, 135). Thymocytes differentiate 
in a stepwise process that involves the somatic rearrangement 
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of T cell receptor (TCR) genes while migrating in close contact 
with stromal cells and the extracellular matrix (ECM) through-
out thymic compartments (136, 137). In this process, a major 
group of αβ TCR-bearing T cells are produced, which ultimately 
function by recognizing peptide antigens presented by class I or 
class II major histocompatibility complexes (MHC I or MHC II, 
respectively) on the surface of host cells (138). Alternatively, a 
distinct lineage of T cells bearing γδ TCR chains develop, which 
recognize a quite unique group of molecules (139). Noteworthy, 
intrathymic lineage restriction and cell fate are determined not 
only by the type of TCR and its avidity for self-antigens but also by 
the acquisition of co-receptors that relay signals to intracellular 
effectors during T cell activation. Hence, generation of distinct 
cell types are tightly controlled as thymocyte progresses through 
thymic niches (7). Herein, we will point out some key aspects 
of the expression and influence of TGF-β superfamily signaling 
molecules on the distinct paths of thymocyte development: from 
CD4−CD8− DN T cell precursors (further subdivided in DN1 to 
DN4 stages based on the surface expression of CD44 and CD25) 
to the highly expanded immature CD4+CD8+ DP cells, and upon 
the mature CD4+CD8− or CD4−CD8+ SP cells.
DN1 to DN2 Cells
Entry of bone marrow-derived Lin−cKithighCD44+CD25− cells, 
or ETPs, into the thymus occurs through the corticomedullary 
junction. In this intermediate region, these immature cells with 
T cell–B cell–myeloid potential come into contact with K5+K8+ 
bipotent TEPCs and mature T cells (67, 124, 140). They subse-
quently move into the thymus cortex toward the subcapsular zone 
as DN cells, as defined by the lack of CD4 and CD8 co-receptors 
(7, 141). In the cortex, developing thymocytes then upregulate 
CD25 – the α chain of the IL-2 receptor – to become CD44+CD25+ 
DN2 cells, which undergo Dβ to Jβ recombination of the β-chain 
locus (142, 143). This DN1 to DN2 transition is accompanied by 
a strong downregulation of Bmpr1a (Alk3) and Bmpr2 (BMPRII) 
expression (127, 129). Most cells at this stage present high levels 
of pSmad2 along with Alk4 (Acvr1b) and ActRII (Acvr2a) on 
their cell surface, although a few cells also exhibit Alk5 (Tgfbr1) 
and TβRII (Tgfbr2) receptors (134). DN cells also express the type 
III co-receptor betaglycan/TβRIII (Tgfbr3), with highest levels 
at DN3 cells (144). Betaglycan seems to increase the binding 
strength of some ligands with their cognate receptors, therefore 
potentializing their effects (145–147). Thymocytes express no 
Bmpr1b (Alk6), Acvr1 (Alk2), and Acvr1c (Alk7) during thymo-
poiesis (127, 129). Yet, high levels of inhibin βA subunit (Inhba) 
and TGF-β1 (Tgfb1) contrast with reduced levels of the inhibin 
α subunit (Inha), Bmp2, Bmp4, and Bmp7 at the DN2 stage (81, 
82, 127, 130). When Inha mutants were used for E14.0 FTOC, a 
partial arrest at the DN2 stage impaired further T cell maturation 
(148). Likewise, antibody-dependent blocking of betaglycan in 
E14.0 FTOC resulted in a reduction of both DN2 and DP cells 
(144). By contrast, addition of TGF-β1 or TGF-β2 in E14.0 FTOC 
strongly inhibited T cell development by mainly impairing the 
differentiation of DN1 cells into DN2 (149). A slightly less strong 
impact after BMP4 treatment of E15.0–E15.5 FTOC or suspen-
sion cultures of fetal thymocytes resulted in cell cycle arrest at 
the DN1 stage without induction of apoptosis (89,  150). The 
use of BMP4-treated chimeric human–mouse FTOC produced 
similar findings (81), revealing a conserved role for Bmp4 during 
evolution. Besides, partial redundancy between BMP ligands 
also seems to occur in the thymus, since treatment of FTOC with 
BMP2, but not with BMP7, similarly affected the production of 
DP cells (150).
DN2 to DN3 Cells
Following T cell differentiation into CD44−/lowCD25+ DN3 cells, 
Vβ to DJβ recombination gives rise to the β chain of the pre-TCR 
(143). At this stage, the levels of Inha, Bmp2, and Bmp4 remain 
relatively low, Bmp7 becomes upregulated up to the CD3−CD8+ 
intermediate single-positive (ISP) stage, and expression of Inhba 
and Tgfb1 declines (82, 127, 130). Levels of Alk4 (Acvr1c), Alk5 
(Tgfbr1), and ActRII (Acvr2a) gradually reduce as thymocytes 
mature, in contrast to TβRII, which is slowly upregulated  –  at 
this stage, Alk4 and Alk5 are co-expressed (134). Expression of 
Bmpr1a (Alk3) and Bmpr2 (BMPRII) presents a small recovery 
at the DN3 and DN4 stages (127, 129). Nevertheless, conditional 
inactivation of Bmp7 in the hematopoietic lineage using a vav-
iCre line had no significant impact on T cell differentiation and 
total cell numbers, likely because endoderm-derived cTECs and 
mTECs may supply enough Bmp7 or other redundant factor for 
the mutant thymocytes (71, 82, 150). In particular, subcapsular 
cTECs, cortical DCs, and mTECs express Bmp2 and Bmp4 (71, 
81, 82). Activation of the Bmp4 pathway in stromal cells indi-
rectly impacts the DN to DP transition, as revealed by reconstitu-
tion experiments with thymocyte-depleted stroma treated with 
BMP4 or untreated stroma with BMP4-treated DN cells (89). Of 
note, although highly expressed up to the transition from DN2 
to DN3, being downregulated up to the DP stage, and sustained 
at low levels at SP subsets (127), the gene referred as Bmp1 is a 
procollagen C-proteinase involved in ventral body wall closure 
during embryogenesis. To our knowledge, there is no available 
functional information regarding its role during thymopoiesis, 
except that it was also found in cTECs and mTECs (71, 151).
DN3 to DN4 Cells
Should rearrangements result in unproductive β chains, DN3 cells 
undergo apoptosis and are phagocytized by cortical macrophages 
or DCs in a process termed β-selection (143, 152). Otherwise, 
successful recombination leads to a reduction in CD25 expres-
sion and the expansion of CD44−CD25− DN4 thymocytes (153, 
154). Both activin A and inhibin A similarly stimulate the DN3 
to DN4 transition, as revealed in FTOC from wild-type fetuses at 
E14.0. However, treatment with activin A led to higher numbers 
of mature CD24lowCD8+TCRβhigh T cells at the expense of CD4+ 
cells, in contrast to inhibin A treatment, which stimulated the 
transition from DN4 to DP cells (148).
DP Cells
Rearrangement of the TCRα chain occurs at the DP stage and 
cells move from the cortical zone toward the thymic medulla 
(143, 155). During this migration, cTECs present self peptides 
through MHC molecules (pMHC) to the TCR of intermingling 
DP thymocytes in a process known as positive selection, in which 
interactions of low-avidity drive clones to survive and continue 
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maturation (156). At the DP stage, Alk4 (Acvr1b), Alk5 (Tgfbr1), 
and ActRII (Acvr2a) reach their lowest levels, but the number 
of cells concomitantly presenting Alk5 and pSmad2 increases 
in relation to Alk4-positive cells (134). By contrast, Bmpr1a 
(Alk3) and Bmpr2 (BMPRII) are highly expressed (127, 129). 
Two members of the GDF subgroup, Gdf7 and Gdf11, seem to be 
induced in DP cells and sustained at SP stages, with CD4+ T cells 
presenting relatively higher levels than CD8+ T cells (127). Gdf7 
signals through BMP-specific receptors as Alk3 and BMPRII, 
whereas Gdf11 binds TGF-β-related receptors, as Alk4 and Alk5 
(157–159). Their roles on T cell function are largely obscure, 
if any. Mouse mutants for Gdf7 exhibit variable hydrocephalus 
and fail to produce a class of commissural neurons (160). Male 
mutants are sterile due to impaired differentiation and branching 
morphogenesis of the seminal vesicle, with no other affected 
reproductive structure (161). In turn, mutants for Gdf11 show 
homeotic transformations due to a delayed trunk to tail transi-
tion (162, 163). They die after birth because of renal defects, 
which may vary from hypoplasia to complete bilateral agenesis 
(164). Curiously, oral infection with Gram-negative bacteria, 
Aggregatibacter actinomycetemcomitans, in rats led to a chronic 
upregulation of Gdf11 expression among other cytokines in both 
peripheral CD45RA+CD4+ T cells and B cells (165). At present, 
however, little is known on the effects of GDFs over thymopoiesis.
SP Cells
Still in the cortex, differentiating thymocytes start to lose the 
expression of either CD4 or CD8 and migrate toward the medulla. 
The choice for either CD4 or CD8 SP lineage seems to occur at 
a transitional step defined as CD4+CD8low and depends on TCR 
interaction with the MHC class II or class I, respectively (166, 
167). Additionally, it also relies on the triggering of a transcrip-
tional machinery that operates distinctly for final differentiation 
(165, 166). Noteworthy, the SP cells sustain Bmpr1a (Alk3) and 
Bmpr2 (BMPRII) expression, and upregulate Alk5 (Tgfbr1) and 
TβRII (Tgfbr2), which lead to increased levels of pSmad2 (84, 127, 
129, 134). At this stage, fine-tuning of TGF-β signaling may occur 
by type III co-receptors  –  CD4+CD8− cells upregulate Tgfbr3 
(betaglycan), whereas CD4−CD8+ cells exhibit higher levels of 
Cripto (Tdgf1) (127, 144). Genetic loss of Tgfbr3 in FTOC resulted 
in decreased numbers of both DP and SP cells, probably related to 
the high rates of apoptosis in DN, DP, and CD4+ SP subsets (144). 
An apoptotic phenotype was also observed in the liver of Tgfbr3 
mutants (168). However, a functional role for Cripto during 
thymopoiesis is currently unresolved, despite its importance for 
TGF-β binding and inhibition (169). Mutants for this gene present 
a strong deleterious phenotype during gastrulation and die shortly 
afterward (170, 171). Modulation of TGF-β family members, their 
receptors, and co-receptors at the DP stage is therefore associated 
with the terminal differentiation of thymocytes.
impact of TGF-β Signals on the 
Differentiation of Thymic 
Regulatory T Cells
Regulatory T (Treg) cells have the ability to suppress autoreactive 
T cells, and they can originate from the thymus or be induced 
in the periphery (172). Thymus-derived Treg (tTreg) arise in 
the thymus from SP CD4+ T cells that escape negative selection 
during maturation by presenting TCR signals of variable affini-
ties (80, 172–174). More specifically, TCRs with high avidity for 
self-antigens trigger a new upregulation of CD25 (IL-2 receptor 
α chain) and therefore exhibit an increased responsiveness to 
IL-2, ultimately inducing the expression of the transcription 
factor forkhead box P3 (Foxp3) through a STAT5-dependent 
mechanism (175–177). Foxp3 is the critical transcription factor 
for Treg cell lineage, as its loss abolishes tTreg cells and lead to 
systemic autoimmunity and death (178, 179). Conversely, forced 
expression of Foxp3 in CD25−CD45RBhighCD4+ SP cells trans-
ferred into severe combined immunodeficiency (SCID) hosts 
suppressed exacerbated inflammation (180). Unlike previously 
thought (181), however, expression of Foxp3 in developing tTreg 
cells induced apoptosis instead of cell survival. Cell death is pre-
vented by limiting concentrations of γc-mediated survival signals 
enough to sustain only fewer than one million Foxp3+ cells (182).
Signals from members of TGF-β superfamily also play impor-
tant roles over the differentiation and survival of tTreg cells. In 
particular, conditional loss of Tgfbr1 (Alk5) in thymocytes seems 
to be involved in tTreg specification, since a Lck–Cre mouse line 
completely blocked differentiation of tTreg cells in neonatal mice, 
whereas later inactivation of Tgfbr1 by a Foxp3–Cre line produced 
no differences in tTreg numbers as compared to wild-type mice 
(80, 183). In addition, the intrathymic injection of an anti-TGF-β 
antibody suppressed Foxp3 expression in a TCR transgenic 
CD4+CD25− SP cells (80). Of note, impaired Alk5 signaling 
induced by the Lck–Cre line caused no significant impact on 
CD4+ and CD8+ SP cell numbers (183). A later increase in Treg 
cells induced in the periphery (pTreg) in these mutant mice 
relied on IL-2 signaling, since ablation of this cytokine produced 
no detectable cells in organs, such as the spleen and liver (183). 
Similarly, thymocyte deficiency of Tgfbr2 from a CD4–Cre mouse 
line resulted in reduced numbers of tTreg cells due to Bim-
dependent apoptosis likely independent of γc-signaling, without 
affecting TCR-βhighCD4+Foxp3− mature T cells in neonatal mice 
(84). Unlike Tfgbr1-mutant thymocytes, conditional deletion of 
Tgfbr2 also resulted in low numbers of pTreg cells (84). Induction 
of pTreg cells relies on the Smad3-dependent upregulation of 
Foxp3 triggered by activation of both TCR and TGF-β signal-
ing and facilitated by retinoic acid, which increased pSmad3 
accessibility to regulatory sequences of the Foxp3 promoter and 
concurrently counteracted the suppressing effects of a c-Jun 
N-terminal Kinase (JNK) inhibitor (184, 185). Genetic analyses 
of the regulatory CNS1 region of Foxp3, which contains binding 
sites for NFAT, Smad3, and RAR/RXR, revealed that tTreg cell 
development occurs independently of its activation, whereas its 
chromosomal deletion largely impaired the production of pTreg 
cells in secondary lymphoid organs (184–186). In accordance 
to the different requirements revealed for tTreg in comparison 
to pTreg populations, TGF-β1 is essential for the peripheral 
differentiation and maintenance of pTreg cells, but seems to be 
dispensable for tTreg maturation (187).
Taking into consideration the upregulation of all three TGF-
β ligands by stromal cells upon thymocyte apoptosis in the 
thymus, along with recent findings regarding mutants for distinct 
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TGF-β-specific receptors (80, 84, 183), it is possible that TGF-β 
ligands may play a redundant yet underestimated role in the 
immune system. Noteworthy, mutants for TGF-β2 and TGF-β3 
also exhibit perinatal mortality, a characteristic that complicates 
the examination of their role in adults (188–190). Although at 
first sight, the phenotypes observed in these mutants were gener-
ally non-overlapping, some particular structures showed similar 
defects between single mutants (e.g., cleft palate in either TGF-β2 
and TGF-β3 mutants) or exclusive abnormalities in compound 
mutants, such as abnormal brain vascular morphogenesis and 
impaired midline fusion along with earlier embryonic lethality in 
Tgfb1RGE;Tgfb3 and Tgfb2;Tgfb3 compound mutants, respectively 
(191, 192). However, development of tTreg was never evaluated 
in these compound mutants. An alternative explanation may con-
sider the participation of a previously unappreciated ligand of the 
TGF-β superfamily in the differentiation of tTreg cells. Whether 
this is indeed the case, this candidate ligand should probably 
signal through Alk5 and TβRII receptors to phosphorylate Smad2 
and Smad3 intracellular effectors. Thereby, likely ligands to be 
thoroughly evaluated due to their expression pattern and receptor 
affinity are Gdf11 and Gdf8/myostatin – curiously two members 
that showed redundancy in patterning the axial skeleton as 
revealed by Gdf11;Mstn double mutants. Unfortunately, examina-
tion of fetal thymus morphology and T cell differentiation using 
FTOC was not performed in these mutants (193).
Noteworthy, TGF-β signals also regulate the thymic develop-
ment of IL-17-producing cells. A subset of γδ T cells acquire 
the capacity to produce IL-17 inside the thymus via a TGF-β1-
dependent machinery, and both Tgfβ1−/− and Smad3−/− mice 
were shown to be completely devoid of IL-17-producing γδ 
T  cells (194). Additionally, NKT17 cells comprise a thymic-
derived IL-17-producing, CD1d-restricted, and glycolipid 
antigen-reactive T cell subset (195, 196). These cells express high 
levels of TβRII and depend on TGF-β signals for differentiation 
and survival within the thymus and in the periphery (197, 198).
A TGF-β Member for Thymus 
Rejuvenation?
Aging is an inherent process of living beings, normally associated 
with gradual loss of function and structure over time – accumula-
tion of reactive species, DNA damage, abnormally folded proteins, 
and telomere shortening are just some of the molecular changes 
that may be followed by increased apoptosis, cell transformation, 
or other cellular event that will ultimately lead to death (199). 
Although this negative scenario was initially thought to be 
irreversible, numerous evidences point out that at least in part 
it is possible to slow down or eventually reverses some specific 
aging phenotypes. Taking the thymus as example, aging is easily 
recognizable by a sharp decrease in cellularity of both lymphoid 
and stromal compartments, whereas the number of thymic adi-
pocytes inversely increases (200, 201). Ultimately, these thymic 
changes lead to a reduction of naïve T cells in the periphery along 
with an increase of memory T cells, which reflects in the organ-
ism ability to respond to both infection and tumorigenesis (202).
Multiple factors may trigger thymic involution, including 
the production of sex steroid hormones from puberty, increased 
calorie intake, or diminished levels of some growth factors and 
cytokines, such as fibroblast growth factor 7 (FGF7)/keratinocyte 
growth factor (KGF), insulin-like growth factor (IGF-1), growth 
hormone (GH), interleukin-7 (IL-7), and IL-22 (203). Modulation 
of each of them is able to rescue the aged thymic phenotype and 
restore the immune function at some level (204–210). However, 
some of these strategies may be inefficient, invasive, non-specific, 
or produce undesirable side effects to be used in humans (211). A 
quest for thymic rejuvenation therapies therefore faces daunting 
challenges in the clinic. Of particular interest, forced expression 
of Foxn1 was shown to effectively reprogram fibroblasts into TECs 
or regenerate fully involuted thymuses at many different experi-
mental setups, both in vitro or in vivo (212–214). In this context, 
signals that control Foxn1 expression might be used to restore the 
integrity of the thymic epithelial niche and subsequently flourish 
thymopoisesis in the elderly. In this scenario, administration of 
soluble factors, such as ligands of the TGF-β superfamily, may be 
used as regenerative drugs.
Recent findings have revealed that levels of some circulating 
factors vary with age and that heterochronic parabiosis, i.e., a sur-
gical procedure that connects the circulatory systems of animals 
with different ages, was able to reverse age-related phenotypes as 
cardiac hypertrophy (132). These authors further identified the 
TGF-β member Gdf11 as responsible for restoring cardiac func-
tion in old mice, a finding that was further expanded to other sys-
tems. In particular, daily treatment of old mice with recombinant 
GDF11 improved skeletal muscle mass and strength, as well as the 
integrity of brain vasculature and cognitive function (215, 216). 
In culture, Gdf11 promoted osteoblastogenesis while inhibiting 
adipogenesis in bone marrow-derived cells (217). Administration 
of GDF11 in endothelial progenitor cells triggered cell sprouting 
and migration, also revealing a role in the formation of blood 
vessels (218).
Whether Gdf11 or other circulating factor can be used as a 
rejuvenating cytokine for the thymus remains to be thoroughly 
assessed. Indeed, Gdf11 is expressed in the thymus of young mice 
(132), whereas the levels of its non-exclusive receptors, Alk4 and 
Alk5, vary in thymocytes and TECs, as previously discussed. Of 
note, however, therapy with Gdf11 produced some side effects 
in mice (219), and a recent study by Egerman et al. has recently 
questioned the aforementioned observations (220). Whereas 
these controversial data on Gdf11 await further investigation, 
it is noteworthy that heterochronic parabiosis did not reverse 
thymic involution, but caused atrophy with mild effects on T cell 
subpopulations of young mice and a reduction in the number of 
CD4+CD25+Foxp3+ regulatory T cells in old partners to the level 
of the young pair (221). Although a putative rejuvenating factor 
for the thymus still awaits to be determined, this controversial 
matter helps to bring the debate on the role of TGF-β superfamily 
members for the thymus function.
Concluding Remarks
Although the differentiation of T cells is mainly driven by the 
rearrangement of TCR genes, many members of the TGF-β 
superfamily exert critical roles in their stepwise progression 
during thymic migration. Historically, special attention had been 
August 2015 | Volume 6 | Article 44210
Jurberg et al. TGF-β superfamily in the thymus
Frontiers in Immunology | www.frontiersin.org
References
 1. Flajnik MF, Kasahara M. Origin and evolution of the adaptive immune sys-
tem: genetic events and selective pressures. Nat Rev Genet (2010) 11:47–59. 
doi:10.1038/nrg2703 
 2. Cowan JE, Jenkinson WE, Anderson G. Thymus medulla fosters generation 
of natural Treg cells, invariant γδ T cells, and invariant NKT cells: what 
we learn from intrathymic migration. Eur J Immunol (2015)  45:652–60. 
doi:10.1002/eji.201445108 
 3. Agosti V, Corbacioglu S, Ehlers I, Waskow C, Sommer G, Berrozpe G, et al. 
Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro 
T and pro B cell development. J Exp Med (2004) 199:867–78. doi:10.1084/
jem.20031983 
 4. Fry TJ, Sinha M, Milliron M, Chu YW, Kapoor V, Gress RE, et al. Flt3 ligand 
enhances thymic-dependent and thymic-independent immune reconstitu-
tion. Blood (2004) 104:2794–800. doi:10.1182/blood-2003-11-3789 
 5. Besseyrias V, Fiorini E, Strobl LJ, Zimber-strobl U, Dumortier A, Koch 
U, et  al. Hierarchy of Notch–Delta interactions promoting T cell lineage 
commitment and maturation. J Exp Med (2007) 204:331–43. doi:10.1084/
jem.20061442 
 6. Magri M, Yatim A, Benne C, Balbo M, Henry A, Serraf A, et al. Notch ligands 
potentiate IL-7-driven proliferation and survival of human thymocyte pre-
cursors. Eur J Immunol (2009) 39:1231–40. doi:10.1002/eji.200838765 
 7. Petrie HT, Zúñiga-Pflücker JC. Zoned out: functional mapping of stromal 
signaling microenvironments in the thymus. Annu Rev Immunol (2007) 
25:649–79. doi:10.1146/annurev.immunol.23.021704.115715 
 8. Urist MR. Bone: formation by autoinduction. Science (1965) 150:893–9. 
doi:10.1126/science.150.3698.893 
 9. De Larco JE, Todaro GJ. Growth factors from murine sarcoma virus-trans-
formed cells. Proc Natl Acad Sci U S A (1978) 75:4001–5. doi:10.1073/
pnas.75.8.4001 
 10. Roberts AB, Lamb LC, Newton DL, Sporn MB, De Larco JE, Todaro GJ. 
Transforming growth factors: isolation of polypeptides from virally and 
chemically transformed cells by acid/ethanol extraction. Proc Natl Acad Sci 
U S A (1980) 77:3494–8. doi:10.1073/pnas.77.6.3494 
 11. Frolik CA, Dart LL, Meyers CA, Smith DM, Sporn MB. Purification and 
initial characterization of a type beta transforming growth factor from 
human placenta. Proc Natl Acad Sci U S A (1983) 80:3676–80. doi:10.1073/
pnas.80.12.3676 
 12. Wrana JL. Signaling by the TGFβ superfamily. Cold Spring Harb Perspect Biol 
(2013) 5:a011197. doi:10.1101/cshperspect.a011197 
 13. Constam DB. Regulation of TGFβ and related signals by precursor process-
ing. Semin Cell Dev Biol (2014) 32:85–97. doi:10.1016/j.semcdb.2014.01.008 
 14. Degnin C, Jean F, Thomas G, Christian JL. Cleavages within the prodomain 
direct intracellular trafficking and degradation of mature bone morphogenetic 
protein-4. Mol Biol Cell (2004) 15:5012–20. doi:10.1091/mbc.E04-08-0673 
 15. Nelsen SM, Christian JL. Site-specific cleavage of BMP4 by furin, PC6, and 
PC7. J Biol Chem (2009) 284:27157–66. doi:10.1074/jbc.M109.028506 
 16. Li Z, Kawasumi M, Zhao B, Moisyadi S, Yang J. Transgenic over-expression 
of growth differentiation factor 11 propeptide in skeleton results in transfor-
mation of the seventh cervical vertebra into a thoracic vertebra. Mol Reprod 
Dev (2010) 77(11):990–7. doi:10.1002/mrd.21252 
 17. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J. Mechanism of activation 
of the TGF-beta receptor. Nature (1994) 370:341–7. doi:10.1038/370341a0 
 18. Kretzschmar M, Liu F, Hata A, Doody J, Massagué J. The TGF-β family 
mediator Smad1 is phosphorylated directly and activated functionally by the 
BMP receptor kinase. Genes Dev (1997) 11:984–95. doi:10.1101/gad.11.8.984 
 19. Massagué J, Gomis RR. The logic of TGFβ signaling. FEBS Lett (2006) 
580:2811–20. doi:10.1016/j.febslet.2006.04.033 
 20. Mueller TD, Nickel J. Promiscuity and specificity in BMP receptor activation. 
FEBS Lett (2012) 586:1846–59. doi:10.1016/j.febslet.2012.02.043 
 21. Ten Dijke P, Ichijo H, Franzén P, Schulz P, Saras J, Toyoshima H, et al. Activin 
receptor-like kinases: a novel subclass of cell-surface receptors with predicted 
serine/threonine kinase activity. Oncogene (1993) 8:2879–87. 
 22. Wu G, Chen YG, Ozdamar B, Gyuricza CA, Chong PA, Wrana JL, et  al. 
Structural basis of Smad2 recognition by the Smad anchor for receptor 
activation. Science (2000) 287:92–7. doi:10.1126/science.287.5450.92 
 23. Shi Y, Wang YF, Jayaraman L, Yang H, Massagué J, Pavletich NP. Crystal struc-
ture of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-
beta signaling. Cell (1998) 94:585–94. doi:10.1016/S0092-8674(00)81600-1 
 24. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B, et al. Human 
Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 
(1998) 1:611–7. doi:10.1016/S1097-2765(00)80061-1 
 25. Makkar P, Metpally RPR, Sangadala S, Reddy BVB. Modeling and analysis of 
MH1 domain of Smads and their interaction with promoter DNA sequence 
motif. J Mol Graph Model (2009) 27:803–12. doi:10.1016/j.jmgm.2008.12.003 
 26. Xiao Z, Latek R, Lodish HF. An extended bipartite nuclear localization signal 
in Smad4 is required for its nuclear import and transcriptional activity. 
Oncogene (2003) 22:1057–69. doi:10.1038/sj.onc.1206212 
 27. Chacko BM, Qin BY, Tiwari A, Shi G, Lam S, Hayward LJ, et al. Structural 
basis of heteromeric smad protein assembly in TGF-beta signaling. Mol Cell 
(2004) 15:813–23. doi:10.1016/j.molcel.2004.07.016 
 28. Baburajendran N, Jauch R, Tan CYZ, Narasimhan K, Kolatkar PR. Structural 
basis for the cooperative DNA recognition by Smad4 MH1 dimers. Nucleic 
Acids Res (2011) 39:8213–22. doi:10.1093/nar/gkr500 
 29. Chen X, Xu L. Specific nucleoporin requirement for Smad nuclear transloca-
tion. Mol Cell Biol (2010) 30:4022–34. doi:10.1128/MCB.00124-10 
 30. Cautain B, Hill R, de Pedro N, Link W. Components and regulation of nuclear 
transport processes. FEBS J (2015) 282:445–62. doi:10.1111/febs.13163 
 31. Morikawa M, Koinuma D, Miyazono K, Heldin C-H. Genome-wide mecha-
nisms of Smad binding. Oncogene (2012) 32:1–7. doi:10.1038/onc.2012.191 
 32. Ross S, Hill CS. How the Smads regulate transcription. Int J Biochem Cell Biol 
(2008) 40:383–408. doi:10.1016/j.biocel.2007.09.006 
 33. Shi Y, Massagué J. Mechanisms of TGF-beta signaling from cell membrane to 
the nucleus. Cell (2003) 113:685–700. doi:10.1016/S0092-8674(03)00432-X 
 34. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, et  al. 
Smad6 inhibits signalling by the TGF-beta superfamily. Nature (1997) 
389:622–6. doi:10.1038/39355 
 35. Hanyu A, Ishidou Y, Ebisawa T, Shimanuki T, Imamura T, Miyazono K. 
The N domain of Smad7 is essential for specific inhibition of transforming 
growth factor-beta signaling. J Cell Biol (2001) 155:1017–27. doi:10.1083/
jcb.200106023 
 36. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, 
et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the 
given to the activity of TGF-β ligands in the induction of Treg 
cells and tolerance to self-antigens, as well as to BMP signaling 
on thymus organogenesis. However, other members are also 
produced by developing thymocytes, thymic stromal cells, or 
may circulate throughout the body by the blood stream and reach 
the thymus. These ligands signal through the same limited sets 
of type I and type II receptors to produce dissimilar outcomes 
either by affecting distinct stages or cell types (e.g., thymocytes 
versus TECs). How such TGF-β superfamily ligands affect T cell 
maturation, thymus proper physiology, or its involution remain 
poorly understood and should be the focus of future research. In 
addition, a scenario in which a TGF-β superfamily member or its 
inhibitor acts to rejuvenate the aged thymus may be a likely case 
for future research.
Acknowledgments
This work benefited from data assembled by the ImmGen con-
sortium and was supported by grants from the Brazilian Research 
Council/Conselho Nacional de Desenvolvimento Científico e 
Tecnológico (CNPq) and Rio de Janeiro State Research Council/
Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado 
do Rio de Janeiro (FAPERJ) (to ADJ and VC-A). LV-F received a 
Masters’ fellowship from CNPq.
August 2015 | Volume 6 | Article 44211
Jurberg et al. TGF-β superfamily in the thymus
Frontiers in Immunology | www.frontiersin.org
TGFβ receptor for degradation. Mol Cell (2000) 6:1365–75. doi:10.1016/
S1097-2765(00)00134-9 
 37. Feng X-H, Derynck R. Specificity and versatility in Tgf-beta signaling 
through Smads. Annu Rev Cell Dev Biol (2005) 21:659–93. doi:10.1146/
annurev.cellbio.21.022404.142018 
 38. Wu MY, Hill CS. Tgf-beta superfamily signaling in embryonic development 
and homeostasis. Dev Cell (2009) 16:329–43. doi:10.1016/j.devcel.2009.02.012 
 39. Massagué J, Xi Q. TGF-β control of stem cell differentiation genes. FEBS Lett 
(2012) 586:1953–8. doi:10.1016/j.febslet.2012.03.023 
 40. Xie F, Zhang Z, van Dam H, Zhang L, Zhou F. Regulation of TGF-β super-
family signaling by SMAD mono-ubiquitination. Cells (2014) 3:981–93. 
doi:10.3390/cells3040981 
 41. Gordon J, Wilson VA, Blair NF, Sheridan J, Farley A, Wilson L, et  al. 
Functional evidence for a single endodermal origin for the thymic epithe-
lium. Nat Immunol (2004) 5:546–53. doi:10.1038/ni1064 
 42. Gordon J, Manley NR. Mechanisms of thymus organogenesis and morpho-
genesis. Development (2011) 138:3865–78. doi:10.1242/dev.059998 
 43. Sadler TW. Langman’s Medical Embryology. 12th ed. Philadelphia, PA: 
Lippincott Williams & Wilkins (2012).
 44. Farley AM, Morris LX, Vroegindeweij E, Depreter MLG, Vaidya H, Stenhouse 
FH, et al. Dynamics of thymus organogenesis and colonization in early human 
development. Development (2013) 140:2015–26. doi:10.1242/dev.087320 
 45. Manley NR, Capecchi MR. Hox group 3 paralogs regulate the development 
and migration of the thymus, thyroid, and parathyroid glands. Dev Biol 
(1998) 195:1–15. doi:10.1006/dbio.1997.8827 
 46. Hamazaki Y, Fujita H, Kobayashi T, Choi Y, Scott HS, Matsumoto M, 
et  al. Medullary thymic epithelial cells expressing Aire represent a unique 
lineage derived from cells expressing claudin. Nat Immunol (2007) 8:304–11. 
doi:10.1038/ni1438 
 47. Muñoz JJ, Cejalvo T, Tobajas E, Fanlo L, Cortés A, Zapata AG. 3D immunoflu-
orescence analysis of early thymic morphogenesis and medulla development. 
Histol Histopathol (2015) 30:589–99. doi:10.14670/HH-30.589 
 48. Van Ewijk W, Holländer G, Terhorst C, Wang B. Stepwise development 
of thymic microenvironments in  vivo is regulated by thymocyte subsets. 
Development (2000) 127:1583–91. 
 49. Nehls M, Kyewski B, Messerle M, Waldschütz R, Schüddekopf K, Smith AJ, 
et al. Two genetically separable steps in the differentiation of thymic epithe-
lium. Science (1996) 272:886–9. doi:10.1126/science.272.5263.886 
 50. Günther T, Chen ZF, Kim J, Priemel M, Rueger JM, Amling M, et al. Genetic 
ablation of parathyroid glands reveals another source of parathyroid hor-
mone. Nature (2000) 406:199–203. doi:10.1038/35018111 
 51. Gordon J, Bennett AR, Blackburn CC, Manley NR. Gcm2 and Foxn1 
mark early parathyroid- and thymus-specific domains in the developing 
third pharyngeal pouch. Mech Dev (2001) 103:141–3. doi:10.1016/
S0925-4773(01)00333-1 
 52. Liu Z, Farley A, Chen L, Kirby BJ, Kovacs CS, Blackburn CC, et al. Thymus-
associated parathyroid hormone has two cellular origins with distinct 
endocrine and immunological functions. PLoS Genet (2010) 6:e1001251. 
doi:10.1371/journal.pgen.1001251 
 53. Dooley J, Erickson M, Roelink H, Farr AG. Nude thymic rudiment lacking 
functional Foxn1 resembles respiratory epithelium. Dev Dyn (2005) 
233:1605–12. doi:10.1002/dvdy.20495 
 54. Haynes BF, Heinly CS. Early human T cell development: analysis of the 
human thymus at the time of initial entry of hematopoietic stem cells into the 
fetal thymic microenvironment. J Exp Med (1995) 181:1445–58. doi:10.1084/
jem.181.4.1445 
 55. Ramond C, Berthault C, Burlen-Defranoux O, de Sousa AP, Guy-Grand D, 
Vieira P, et al. Two waves of distinct hematopoietic progenitor cells colonize 
the fetal thymus. Nat Immunol (2014) 15:27–35. doi:10.1038/ni.2782 
 56. Jiang X, Rowitch DH, Soriano P, McMahon AP, Sucov HM. Fate of the 
mammalian cardiac neural crest. Development (2000) 127:1607–16. 
 57. Patel SR, Gordon J, Mahbub F, Blackburn CC, Manley NR. Bmp4 and Noggin 
expression during early thymus and parathyroid organogenesis. Gene Expr 
Patterns (2006) 6:794–9. doi:10.1016/j.modgep.2006.01.011 
 58. Gordon J, Patel SR, Mishina Y, Manley NR. Evidence for an early role for 
BMP4 signaling in thymus and parathyroid morphogenesis. Dev Biol (2010) 
339:141–54. doi:10.1016/j.ydbio.2009.12.026 
 59. Neves H, Dupin E, Parreira L, Le Douarin NM. Modulation of Bmp4 sig-
nalling in the epithelial-mesenchymal interactions that take place in early 
thymus and parathyroid development in avian embryos. Dev Biol (2012) 
361:208–19. doi:10.1016/j.ydbio.2011.10.022 
 60. Moore-Scott BA, Opoka R, Lin S-CJ, Kordich JJ, Wells JM. Identification of 
molecular markers that are expressed in discrete anterior-posterior domains 
of the endoderm from the gastrula stage to mid-gestation. Dev Dyn (2007) 
236:1997–2003. doi:10.1002/dvdy.21204 
 61. Sun X, Xu J, Lu H, Liu W, Miao Z, Sui X, et al. Directed differentiation of 
human embryonic stem cells into thymic epithelial progenitor-like cells 
reconstitutes the thymic microenvironment in  vivo. Cell Stem Cell (2013) 
13:230–6. doi:10.1016/j.stem.2013.06.014 
 62. Conlon FL, Lyons KM, Takaesu N, Barth KS, Kispert A, Herrmann B, et al. 
A primary requirement for nodal in the formation and maintenance of the 
primitive streak in the mouse. Development (1994) 120:1919–28. 
 63. Zhang H, Bradley A. Mice deficient for BMP2 are nonviable and have 
defects in amnion/chorion and cardiac development. Development (1996) 
122:2977–86. 
 64. Lawson KA, Dunn NR, Roelen BAJ, Zeinstra LM, Davis AM, Wright CVE, 
et  al. Bmp4 is required for the generation of primordial germ cells in the 
mouse embryo. Genes Dev (1999) 13:424–36. doi:10.1101/gad.13.4.424 
 65. Rossi SW, Jenkinson WE, Anderson G, Jenkinson EJ. Clonal analysis reveals 
a common progenitor for thymic cortical and medullary epithelium. Nature 
(2006) 441:988–91. doi:10.1038/nature04813 
 66. Wong K, Lister NL, Barsanti M, Lim JMC, Hammett MV, Khong DM, et al. 
Multilineage potential and self-renewal define an epithelial progenitor cell 
population in the adult thymus. Cell Rep (2014) 8:1198–209. doi:10.1016/j.
celrep.2014.07.029 
 67. Danzl NM, Jeong S, Choi Y, Alexandropoulos K. Identification of novel 
thymic epithelial cell subsets whose differentiation is regulated by RANKL 
and Traf6. PLoS One (2014) 9:e86129. doi:10.1371/journal.pone.0086129 
 68. Farr AG, Anderson SK. Epithelial heterogeneity in the murine thymus: 
fucose-specific lectins bind medullary epithelial cells. J Immunol (1985) 
134:2971–7. 
 69. Klug DB, Carter C, Crouch E, Roop D, Conti CJ, Richie ER. Interdependence 
of cortical thymic epithelial cell differentiation and T-lineage commitment. 
Proc Natl Acad Sci U S A (1998) 95:11822–7. doi:10.1073/pnas.95.20.11822 
 70. Murata S, Sasaki K, Kishimoto T, Niwa S, Hayashi H, Takahama Y, et  al. 
Regulation of CD8+ T cell development by thymus-specific proteasomes. 
Science (2007) 316:1349–53. doi:10.1126/science.1141915 
 71. St-Pierre C, Brochu S, Vanegas JR, Dumont-Lagacé M, Lemieux S, Perreault 
C. Transcriptome sequencing of neonatal thymic epithelial cells. Sci Rep 
(2013) 3:1860. doi:10.1038/srep01860 
 72. Schluns KS, Grutkoski PS, Cook JE, Engelmann GL, Le PT. Human thymic 
epithelial cells produce TGF-beta 3 and express TGF-beta receptors. Int 
Immunol (1995) 7:1681–90. doi:10.1093/intimm/7.10.1681 
 73. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, et  al. 
Projection of an immunological self shadow within the thymus by the aire 
protein. Science (2002) 298:1395–401. doi:10.1126/science.1075958 
 74. Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D. The 
cellular mechanism of Aire control of T cell tolerance. Immunity (2005) 
23:227–39. doi:10.1016/j.immuni.2005.07.005 
 75. Derbinski J, Gäbler J, Brors B, Tierling S, Jonnakuty S, Hergenhahn M, 
et al. Promiscuous gene expression in thymic epithelial cells is regulated at 
multiple levels. J Exp Med (2005) 202:33–45. doi:10.1084/jem.20050471 
 76. Ohigashi I, Zuklys S, Sakata M, Mayer CE, Zhanybekova S, Murata S, et al. 
Aire-expressing thymic medullary epithelial cells originate from β5t-ex-
pressing progenitor cells. Proc Natl Acad Sci U S A (2013) 110:9885–90. 
doi:10.1073/pnas.1301799110 
 77. Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in 
medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 
(2001) 2:1032–9. doi:10.1038/ni723 
 78. Melichar HJ, Ross JO, Herzmark P, Hogquist KA, Robey EA. Distinct tem-
poral patterns of T cell receptor signaling during positive versus negative 
selection in situ. Sci Signal (2013) 6:ra92. doi:10.1126/scisignal.2004400 
 79. Dzhagalov IL, Chen KG, Herzmark P, Robey EA. Elimination of self-reactive 
T cells in the thymus: a timeline for negative selection. PLoS Biol (2013) 
11:e1001566. doi:10.1371/journal.pbio.1001566 
 80. Konkel JE, Jin W, Abbatiello B, Grainger JR, Chen W. Thymocyte apoptosis 
drives the intrathymic generation of regulatory T cells. Proc Natl Acad Sci U 
S A (2014) 111:E465–73. doi:10.1073/pnas.1320319111 
August 2015 | Volume 6 | Article 44212
Jurberg et al. TGF-β superfamily in the thymus
Frontiers in Immunology | www.frontiersin.org
 81. Cejalvo T, Sacedón R, Hernández-López C, Diez B, Gutierrez-Frías C, Valencia 
J, et  al. Bone morphogenetic protein-2/4 signalling pathway components 
are expressed in the human thymus and inhibit early T-cell development. 
Immunology (2007) 121:94–104. doi:10.1111/j.1365-2567.2007.02541.x 
 82. Passa O, Tsalavos S, Belyaev NN, Petryk A, Potocnik AJ, Graf D. 
Compartmentalization of bone morphogenetic proteins and their 
antagonists in lymphoid progenitors and supporting microenviron-
ments and functional implications. Immunology (2011) 134:349–59. 
doi:10.1111/j.1365-2567.2011.03495.x 
 83. Kersten C, Sivertsen EA, Hystad ME, Forfang L, Smeland EB, Myklebust 
JH. BMP-6 inhibits growth of mature human B cells; induction of Smad 
phosphorylation and upregulation of Id1. BMC Immunol (2005) 6:9. 
doi:10.1186/1471-2172-6-9 
 84. Ouyang W, Beckett O, Ma Q, Li MO. Transforming growth factor-beta 
signaling curbs thymic negative selection promoting regulatory T cell devel-
opment. Immunity (2010) 32:642–53. doi:10.1016/j.immuni.2010.04.012 
 85. Hauri-Hohl M, Zuklys S, Holländer GA, Ziegler SF. A regulatory role for 
TGF-β signaling in the establishment and function of the thymic medulla. 
Nat Immunol (2014) 15:554–61. doi:10.1038/ni.2869 
 86. Marrella V, Poliani PL, Notarangelo LD, Villa A. Rag defects and thymic 
stroma: lessons from animal models. Front Immunol (2014) 5:529. 
doi:10.3389/fimmu.2014.00259 
 87. Nehls M, Pfeifer D, Schorpp M, Hedrich H, Boehm T. New member of the 
winged-helix protein family disrupted in mouse and rat nude mutations. 
Nature (1994) 372:103–7. doi:10.1038/372103a0 
 88. Balciunaite G, Keller MP, Balciunaite E, Piali L, Zuklys S, Mathieu YD, et al. 
Wnt glycoproteins regulate the expression of FoxN1, the gene defective in 
nude mice. Nat Immunol (2002) 3:1102–8. doi:10.1038/ni850 
 89. Tsai PT, Lee RA, Wu H. BMP4 acts upstream of FGF in modulating thymic 
stroma and regulating thymopoiesis. Blood (2003) 102:3947–53. doi:10.1182/
blood-2003-05-1657 
 90. Bleul CC, Boehm T. BMP signaling is required for normal thymus develop-
ment. J Immunol (2005) 175:5213–21. doi:10.4049/jimmunol.175.8.5213 
 91. Talaber G, Kvell K, Varecza Z, Boldizsar F, Parnell SM, Jenkinson EJ, et al. 
Wnt-4 protects thymic epithelial cells against dexamethasone-induced 
senescence. Rejuvenation Res (2011) 14:241–8. doi:10.1089/rej.2010.1110 
 92. Liang C-C, You L-R, Yen JJ, Liao N-S, Yang-Yen H-F, Chen C-M. Thymic 
epithelial β-catenin is required for adult thymic homeostasis and function. 
Immunol Cell Biol (2013) 91:511–23. doi:10.1038/icb.2013.34 
 93. Lai L, Jin J. Generation of thymic epithelial cell progenitors by mouse embry-
onic stem cells. Stem Cells (2009) 27:3012–20. doi:10.1002/stem.238 
 94. D’Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE. Efficient 
differentiation of human embryonic stem cells to definitive endoderm. Nat 
Biotechnol (2005) 23:1534–41. doi:10.1038/nbt1163 
 95. Green MD, Chen A, Nostro M-C, d’Souza SL, Schaniel C, Lemischka IR, 
et al. Generation of anterior foregut endoderm from human embryonic and 
induced pluripotent stem cells. Nat Biotechnol (2011) 29:267–72. doi:10.1038/
nbt.1788 
 96. Parent AV, Russ HA, Khan IS, Laflam TN, Metzger TC, Anderson MS, et al. 
Generation of functional thymic epithelium from human embryonic stem 
cells that supports host T cell development. Cell Stem Cell (2013) 13:219–29. 
doi:10.1016/j.stem.2013.04.004 
 97. Douagi I, Andre I, Ferraz JC, Cumano A. Characterization of T cell precursor 
activity in the murine fetal thymus: evidence for an input of T cell precursors 
between days 12 and 14 of gestation. Eur J Immunol (2000) 30:2201–10. 
doi:10.1002/1521-4141(2000)30:8<2201:AID-IMMU2201>3.0.CO;2-2 
 98. Liu C, Ueno T, Kuse S, Saito F, Nitta T, Piali L, et al. The role of CCL21 in 
recruitment of T-precursor cells to fetal thymi. Blood (2005) 105:31–9. 
doi:10.1182/blood-2004-04-1369 
 99. Liu C, Saito F, Liu Z, Lei Y, Uehara S, Love P, et  al. Coordination 
between CCR7- and CCR9-mediated chemokine signals in prevascular 
fetal thymus colonization. Blood (2006) 108:2531–9. doi:10.1182/
blood-2006-05-024190 
 100. Calderón L, Boehm T. Three chemokine receptors cooperatively regulate 
homing of hematopoietic progenitors to the embryonic mouse thymus. Proc 
Natl Acad Sci U S A (2011) 108:7517–22. doi:10.1073/pnas.1016428108 
 101. Bleul CC, Boehm T. Chemokines define distinct microenviron-
ments in the developing thymus. Eur J Immunol (2000) 30:3371–9. 
doi:10.1002/1521-4141(2000012)30:12<3371:AID-IMMU3371>3.0.CO;2-L 
 102. Zaballos A, Gutiérrez J, Varona R, Ardavín C, Márquez G. Cutting edge: 
identification of the orphan chemokine receptor GPR-9-6 as CCR9, the 
receptor for the chemokine TECK. J Immunol (1999) 162:5671–5. 
 103. Youn BS, Kim CH, Smith FO, Broxmeyer HE. TECK, an efficacious chemo-
attractant for human thymocytes, uses GPR-9-6/CCR9 as a specific receptor. 
Blood (1999) 94:2533–6. 
 104. Yoshida R, Nagira M, Kitaura M, Imagawa N, Imai T, Yoshie O. Secondary 
lymphoid-tissue chemokine is a functional ligand for the CC chemokine 
receptor CCR7. J Biol Chem (1998) 273:7118–22. doi:10.1074/jbc.273.12.7118 
 105. Jenkinson WE, Rossi SW, Parnell SM, Agace WW, Takahama Y, Jenkinson 
EJ, et  al. Chemokine receptor expression defines heterogeneity in the 
earliest thymic migrants. Eur J Immunol (2007) 37:2090–6. doi:10.1002/
eji.200737212 
 106. Hillyer P, Mordelet E, Flynn G, Male D. Chemokines, chemokine receptors 
and adhesion molecules on different human endothelia: discriminating the 
tissue-specific functions that affect leucocyte migration. Clin Exp Immunol 
(2003) 134:431–41. doi:10.1111/j.1365-2249.2003.02323.x 
 107. Lambrecht S, Smith V, De Wilde K, Coudenys J, Decuman S, Deforce D, et al. 
Growth differentiation factor 15, a marker of lung involvement in systemic 
sclerosis, is involved in fibrosis development but is not indispensable for 
fibrosis development. Arthritis Rheumatol (2014) 66:418–27. doi:10.1002/
art.38241 
 108. Kempf T, Zarbock A, Widera C, Butz S, Stadtmann A, Rossaint J, et  al. 
GDF-15 is an inhibitor of leukocyte integrin activation required for survival 
after myocardial infarction in mice. Nat Med (2011) 17:581–8. doi:10.1038/
nm.2354 
 109. Carrillo-García C, Prochnow S, Simeonova IK, Strelau J, Hölzl-Wenig G, 
Mandl C, et al. Growth/differentiation factor 15 promotes EGFR signalling, 
and regulates proliferation and migration in the hippocampus of neonatal 
and young adult mice. Development (2014) 141:773–83. doi:10.1242/
dev.096131 
 110. Zhao X, Huang Y, Huang Y, Lei P, Peng J, Wu S, et al. Transforming growth 
factor-beta1 upregulates the expression of CXC chemokine receptor 4 
(CXCR4) in human breast cancer MCF-7 cells. Acta Pharmacol Sin (2010) 
31:347–54. doi:10.1038/aps.2009.204 
 111. Yu S, Crawford D, Tsuchihashi T, Behrens TW, Srivastava D. The chemokine 
receptor CXCR7 functions to regulate cardiac valve remodeling. Dev Dyn 
(2011) 240:384–93. doi:10.1002/dvdy.22549 
 112. Park BY, Hong CS, Sohail FA, Saint-Jeannet JP. Developmental expression 
and regulation of the chemokine CXCL14 in Xenopus. Int J Dev Biol (2009) 
53:535–40. doi:10.1387/ijdb.092855bp 
 113. Sierra-Filardi E, Nieto C, Domínguez-Soto A, Barroso R, Sánchez-Mateos P, 
Puig-Kroger A, et al. CCL2 shapes macrophage polarization by GM-CSF and 
M-CSF: identification of CCL2/CCR2-dependent gene expression profile. 
J Immunol (2014) 192:3858–67. doi:10.4049/jimmunol.1302821 
 114. Wang B, Biron C, She J, Higgins K, Sunshine MJ, Lacy E, et al. A block in both 
early T lymphocyte and natural killer cell development in transgenic mice 
with high-copy numbers of the human CD3E gene. Proc Natl Acad Sci U S A 
(1994) 91:9402–6. doi:10.1073/pnas.91.20.9402 
 115. Holländer GA, Wang B, Nichogiannopoulou A, Platenburg PP, van Ewijk W, 
Burakoff SJ, et al. Developmental control point in induction of thymic cortex 
regulated by a subpopulation of prothymocytes. Nature (1995) 373:350–3. 
doi:10.1038/373350a0 
 116. Jenkinson WE, Rossi SW, Jenkinson EJ, Anderson G. Development 
of functional thymic epithelial cells occurs independently of lym-
phostromal interactions. Mech Dev (2005) 122:1294–9. doi:10.1016/j.
mod.2005.08.003 
 117. Ohnemus S, Kanzler B, Jerome-Majewska LA, Papaioannou VE, Boehm 
T, Mallo M. Aortic arch and pharyngeal phenotype in the absence of 
BMP-dependent neural crest in the mouse. Mech Dev (2002) 119:127–35. 
doi:10.1016/S0925-4773(02)00345-3 
 118. Liu Y, Jin Y, Li J, Seto E, Kuo E, Yu W, et al. Inactivation of Cdc42 in neural 
crest cells causes craniofacial and cardiovascular morphogenesis defects. Dev 
Biol (2013) 383:239–52. doi:10.1016/j.ydbio.2013.09.013 
 119. Alt B, Elsalini OA, Schrumpf P, Haufs N, Lawson ND, Schwabe GC, et al. 
Arteries define the position of the thyroid gland during its developmental 
relocalisation. Development (2006) 133:3797–804. doi:10.1242/dev.02550 
 120. Wang J, Nagy A, Larsson J, Dudas M, Sucov HM, Kaartinen V. Defective 
ALK5 signaling in the neural crest leads to increased postmigratory neural 
August 2015 | Volume 6 | Article 44213
Jurberg et al. TGF-β superfamily in the thymus
Frontiers in Immunology | www.frontiersin.org
crest cell apoptosis and severe outflow tract defects. BMC Dev Biol (2006) 
6:51. doi:10.1186/1471-213X-6-51 
 121. Hauri-Hohl MM, Zuklys S, Keller MP, Jeker LT, Barthlott T, Moon AM, et al. 
TGF-beta signaling in thymic epithelial cells regulates thymic involution 
and postirradiation reconstitution. Blood (2008) 112:626–34. doi:10.1182/
blood-2007-10-115618 
 122. Foster K, Sheridan J, Veiga-Fernandes H, Roderick K, Pachnis V, 
Adams R, et al. Contribution of neural crest-derived cells in the embry-
onic and adult thymus. J Immunol (2008) 180:3183–9. doi:10.4049/
jimmunol.180.5.3183 
 123. Crivellato E, Vacca A, Ribatti D. Setting the stage: an anatomist’s view of 
the immune system. Trends Immunol (2004) 25:210–7. doi:10.1016/j.
it.2004.02.008 
 124. Pearse G. Normal structure, function and histology of the thymus. Toxicol 
Pathol (2006) 34:504–14. doi:10.1080/01926230600865549 
 125. Gameiro J, Nagib P, Verinaud L. The thymus microenvironment in regulating 
thymocyte differentiation. Cell Adh Migr (2010) 4:382–90. doi:10.4161/
cam.4.3.11789 
 126. Berrih S, Savino W, Cohen S. Extracellular matrix of the human thymus: 
immunofluorescence studies on frozen sections and cultured epithelial cells. 
J Histochem Cytochem (1985) 33:655–64. doi:10.1177/33.7.3891843 
 127. Heng TSP, Painter MW. The Immunological Genome Project: networks of 
gene expression in immune cells. Nat Immunol (2008) 9:1091–4. doi:10.1038/
ni1008-1091 
 128. Hager-Theodorides AL, Outram SV, Shah DK, Sacedon R, Shrimpton RE, 
Vicente A, et al. Bone morphogenetic protein 2/4 signaling regulates early 
thymocyte differentiation. J Immunol (2002) 169:5496–504. doi:10.4049/
jimmunol.169.10.5496 
 129. Hager-Theodorides AL, Ross SE, Sahni H, Mishina Y, Furmanski AL, 
Crompton T. Direct BMP2/4 signaling through BMP receptor IA regulates 
fetal thymocyte progenitor homeostasis and differentiation to CD4+CD8+ 
double-positive cell. Cell Cycle (2014) 13:324–33. doi:10.4161/cc.27118 
 130. Licona P, Chimal-Monroy J, Soldevila G. Inhibins are the major activin 
ligands expressed during early thymocyte development. Dev Dyn (2006) 
235:1124–32. doi:10.1002/dvdy.20707 
 131. Mingueneau M, Kreslavsky T, Gray D, Heng T, Cruse R, Ericson J, et al. The 
transcriptional landscape of αβ T cell differentiation. Nat Immunol (2013) 
14:619–32. doi:10.1038/ni.2590 
 132. Loffredo FS, Steinhauser ML, Jay SM, Gannon J, Pancoast JR, Yalamanchi 
P, et al. Growth differentiation factor 11 is a circulating factor that reverses 
age-related cardiac hypertrophy. Cell (2013) 153:828–39. doi:10.1016/j.
cell.2013.04.015 
 133. Savino W. Intrathymic T cell migration is a multivectorial process under 
a complex neuroendocrine control. Neuroimmunomodulation (2010) 
17:142–5. doi:10.1159/000258708 
 134. Rosendahl A, Speletas M, Leandersson K, Ivars F, Sideras P. Transforming 
growth factor-beta- and Activin-Smad signaling pathways are activated 
at distinct maturation stages of the thymopoeisis. Int Immunol (2003) 
15:1401–14. doi:10.1093/intimm/dxg139 
 135. Yoshioka Y, Ono M, Osaki M, Konishi I, Sakaguchi S. Differential effects 
of inhibition of bone morphogenic protein (BMP) signalling on T-cell 
activation and differentiation. Eur J Immunol (2012) 42:749–59. doi:10.1002/
eji.201141702 
 136. Sanos SL, Nowak J, Fallet M, Bajenoff M. Stromal cell networks regulate 
thymocyte migration and dendritic cell behavior in the thymus. J Immunol 
(2011) 186:2835–41. doi:10.4049/jimmunol.1003563 
 137. Savino W, Mendes-Da-Cruz DA, Smaniotto S, Silva-Monteiro E, Villa-Verde 
DMS. Molecular mechanisms governing thymocyte migration: combined 
role of chemokines and extracellular matrix. J Leukoc Biol (2004) 75:951–61. 
doi:10.1189/jlb.1003455 
 138. Von Boehmer H. Selection of the T-cell repertoire: receptor-controlled check-
points in T-cell development. Adv Immunol (2004) 84:201–38. doi:10.1016/
S0065-2776(04)84006-9 
 139. Ferreira LMR. Gammadelta T cells: innately adaptive immune cells? Int Rev 
Immunol (2013) 32:223–48. doi:10.3109/08830185.2013.783831 
 140. Luc S, Luis TC, Boukarabila H, Macaulay IC, Buza-Vidas N, Bouriez-Jones T, 
et al. The earliest thymic T cell progenitors sustain B cell and myeloid lineage 
potential. Nat Immunol (2012) 13:412–9. doi:10.1038/ni.2255 
 141. Ciofani M, Zúñiga-Pflücker JC. The thymus as an inductive site for T lymph-
opoiesis. Annu Rev Cell Dev Biol (2007) 23:463–93. doi:10.1146/annurev.
cellbio.23.090506.123547 
 142. Schmitt TM, Ciofani M, Petrie HT, Zúñiga-Pflücker JC. Maintenance of T 
cell specification and differentiation requires recurrent notch receptor-ligand 
interactions. J Exp Med (2004) 200:469–79. doi:10.1084/jem.20040394 
 143. Dudley EC, Petrie HT, Shah LM, Owen MJ, Hayday AC. T cell receptor beta 
chain gene rearrangement and selection during thymocyte development in 
adult mice. Immunity (1994) 1:83–93. doi:10.1016/1074-7613(94)90102-3 
 144. Aleman-Muench GR, Mendoza V, Stenvers K, Garcia-Zepeda EA, Lopez-
Casillas F, Raman C, et al. Betaglycan (TβRIII) is expressed in the thymus 
and regulates T cell development by protecting thymocytes from apoptosis. 
PLoS One (2012) 7:e44217. doi:10.1371/journal.pone.0044217 
 145. López-Casillas F, Wrana JL, Massagué J. Betaglycan presents 
ligand to the TGF beta signaling receptor. Cell (1993) 73:1435–44. 
doi:10.1016/0092-8674(93)90368-Z 
 146. López-Casillas F, Payne HM, Andres JL, Massagué J. Betaglycan can act 
as a dual modulator of TGF-β access to signaling receptors: mapping of 
ligand binding and GAG attachment sites. J Cell Biol (1994) 124:557–68. 
doi:10.1083/jcb.124.4.557 
 147. Eickelberg O, Centrella M, Reiss M, Kashgarian M, Wells RG. Betaglycan 
inhibits TGF-β signaling by preventing type I-type II receptor complex 
formation: glycosaminoglycan modifications alter betaglycan function. J Biol 
Chem (2002) 277:823–9. doi:10.1074/jbc.M105110200 
 148. Licona-Limón P, Alemán-Muench G, Chimal-Monroy J, Macías-Silva 
M, García-Zepeda EA, Matzuk MM, et  al. Activins and inhibins: novel 
regulators of thymocyte development. Biochem Biophys Res Commun (2009) 
381:229–35. doi:10.1016/j.bbrc.2009.02.029 
 149. Plum J, De Smedt M, Leclercq G, Vandekerckhove B. Influence of TGF-beta 
on murine thymocyte development in fetal thymus organ culture. J Immunol 
(1995) 154:5789–98. 
 150. Graf D, Nethisinghe S, Palmer DB, Fisher AG, Merkenschlager M. The 
developmentally regulated expression of Twisted gastrulation reveals a role 
for bone morphogenetic proteins in the control of T cell development. J Exp 
Med (2002) 196:163–71. doi:10.1084/jem.20020276 
 151. Suzuki N, Labosky PA, Furuta Y, Hargett L, Dunn R, Fogo AB, et al. Failure 
of ventral body wall closure in mouse embryos lacking a procollagen 
C-proteinase encoded by Bmp1, a mammalian gene related to Drosophila 
tolloid. Development (1996) 122:3587–95. 
 152. Surh CD, Sprent J. T-cell apoptosis detected in situ during positive and nega-
tive selection in the thymus. Nature (1994) 372:100–3. doi:10.1038/372100a0 
 153. Yamasaki S, Ishikawa E, Sakuma M, Ogata K, Sakata-Sogawa K, Hiroshima 
M, et  al. Mechanistic basis of pre-T cell receptor-mediated autonomous 
signaling critical for thymocyte development. Nat Immunol (2006) 7:67–75. 
doi:10.1038/ni1290 
 154. Crompton T, Moore M, MacDonald HR, Malissen B. Double-negative thy-
mocyte subsets in CD3ζ chain-deficient mice: absence of HSA+CD44-CD25- 
cells. Eur J Immunol (1994) 24:1903–7. doi:10.1002/eji.1830240828 
 155. Petrie HT, Livak F, Schatz DG, Strasser A, Crispe IN, Shortman K. Multiple 
rearrangements in T cell receptor alpha chain genes maximize the pro-
duction of useful thymocytes. J Exp Med (1993) 178:615–22. doi:10.1084/
jem.178.2.615 
 156. Morris GP, Allen PM. How the TCR balances sensitivity and specificity 
for the recognition of self and pathogens. Nat Immunol (2012) 13:121–8. 
doi:10.1038/ni.2190 
 157. Oh SP, Yeo C-Y, Lee Y, Schrewe H, Whitman M, Li E. Activin type IIA and IIB 
receptors mediate Gdf11 signaling in axial vertebral patterning. Genes Dev 
(2002) 16:2749–54. doi:10.1101/gad.1021802 
 158. Mazerbourg S, Sangkuhl K, Luo CW, Sudo S, Klein C, Hsueh AJW. 
Identification of receptors and signaling pathways for orphan bone mor-
phogenetic protein/growth differentiation factor ligands based on genomic 
analyses. J Biol Chem (2005) 280:32122–32. doi:10.1074/jbc.M504629200 
 159. Andersson O, Reissmann E, Ibáñez CF. Growth differentiation factor 11 sig-
nals through the transforming growth factor-beta receptor ALK5 to region-
alize the anterior-posterior axis. EMBO Rep (2006) 7:831–7. doi:10.1038/
sj.embor.7400752 
 160. Lee KJ, Mendelsohn M, Jessell TM. Neuronal patterning by BMPs: a 
requirement for GDF7 in the generation of a discrete class of commissural 
August 2015 | Volume 6 | Article 44214
Jurberg et al. TGF-β superfamily in the thymus
Frontiers in Immunology | www.frontiersin.org
interneurons in the mouse spinal cord. Genes Dev (1998) 12:3394–407. 
doi:10.1101/gad.12.21.3394 
 161. Settle S, Marker P, Gurley K, Sinha A, Thacker A, Wang Y, et al. The BMP 
family member Gdf7 is required for seminal vesicle growth, branching 
morphogenesis, and cytodifferentiation. Dev Biol (2001) 234:138–50. 
doi:10.1006/dbio.2001.0244 
 162. McPherron AC, Lawler AM, Lee SJ. Regulation of anterior/posterior pattern-
ing of the axial skeleton by growth/differentiation factor 11. Nat Genet (1999) 
22:260–4. doi:10.1038/10320 
 163. Jurberg AD, Aires R, Varela-Lasheras I, Nóvoa A, Mallo M. Switching axial 
progenitors from producing trunk to tail tissues in vertebrate embryos. Dev 
Cell (2013) 25:451–62. doi:10.1016/j.devcel.2013.05.009 
 164. Esquela AF, Lee S-J. Regulation of metanephric kidney development by 
growth/differentiation factor 11. Dev Biol (2003) 257:356–70. doi:10.1016/
S0012-1606(03)00100-3 
 165. Li Y, Messina C, Bendaoud M, Fine DH, Schreiner H, Tsiagbe VK. 
Adaptive immune response in osteoclastic bone resorption induced by 
orally administered Aggregatibacter actinomycetemcomitans in a rat 
model of periodontal disease. Mol Oral Microbiol (2010) 25:275–92. 
doi:10.1111/j.2041-1014.2010.00576.x 
 166. Singer A, Adoro S, Park J-H. Lineage fate and intense debate: myths, models 
and mechanisms of CD4- versus CD8-lineage choice. Nat Rev Immunol 
(2008) 8:788–801. doi:10.1038/nri2416 
 167. Adoro S, McCaughtry T, Erman B, Alag A, Van Laethem F, Park J-H, et al. 
Coreceptor gene imprinting governs thymocyte lineage fate. EMBO J (2012) 
31:366–77. doi:10.1038/emboj.2011.388 
 168. Stenvers KL, Tursky ML, Harder KW, Kountouri N, Amatayakul-Chantler 
S, Grail D, et al. Heart and liver defects and reduced transforming growth 
factor beta2 sensitivity in transforming growth factor beta type III recep-
tor-deficient embryos. Mol Cell Biol (2003) 23:4371–85. doi:10.1128/
MCB.23.12.4371-4385.2003 
 169. Gray PC, Shani G, Aung K, Kelber J, Vale W. Cripto binds transforming 
growth factor beta (TGF-beta) and inhibits TGF-beta signaling. Mol Cell Biol 
(2006) 26:9268–78. doi:10.1128/MCB.01168-06 
 170. Ding J, Yang L, Yan YT, Chen A, Desai N, Wynshaw-Boris A, et al. Cripto is 
required for correct orientation of the anterior-posterior axis in the mouse 
embryo. Nature (1998) 395:702–7. doi:10.1038/27215 
 171. Xu C, Liguori G, Persico MG, Adamson ED. Abrogation of the Cripto gene in 
mouse leads to failure of postgastrulation morphogenesis and lack of differ-
entiation of cardiomyocytes. Development (1999) 126:483–94. doi:10.1006/
dbio.1998.8862 
 172. Ohkura N, Kitagawa Y, Sakaguchi S. Development and maintenance of regu-
latory T cells. Immunity (2013) 38:414–23. doi:10.1016/j.immuni.2013.03.002 
 173. Lee HM, Bautista JL, Scott-Browne J, Mohan JF, Hsieh CSA. Broad range of 
self-reactivity drives thymic regulatory T cell selection to limit responses to 
self. Immunity (2012) 37:475–86. doi:10.1016/j.immuni.2012.07.009 
 174. Klein L, Kyewski B, Allen PM, Hogquist KA. Positive and negative selection 
of the T cell repertoire: what thymocytes see (and don’t see). Nat Rev Immunol 
(2014) 14:377–91. doi:10.1038/nri3667 
 175. Zorn E, Nelson EA, Mohseni M, Porcheray F, Kim H, Litsa D, et  al. IL-2 
regulates FOXP3 expression in human CD4+CD25+ regulatory T cells 
through a STAT-dependent mechanism and induces the expansion of these 
cells in vivo. Blood (2006) 108:1571–9. doi:10.1182/blood-2006-02-004747 
 176. Zeiser R, Negrin RS. Interleukin-2 receptor downstream events in regulatory 
T cells: implications for the choice of immunosuppressive drug therapy. Cell 
Cycle (2008) 7:458–62. doi:10.4161/cc.7.4.5454 
 177. Burchill MA, Yang J, Vang KB, Moon JJ, Chu HH, Lio C-WJ, et al. Linked 
T cell receptor and cytokine signaling govern the development of the 
regulatory T cell repertoire. Immunity (2008) 28:112–21. doi:10.1016/j.
immuni.2007.11.022 
 178. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, et al. 
Disruption of a new forkhead/winged-helix protein, scurfin, results in the 
fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet (2001) 
27:68–73. doi:10.1038/83784 
 179. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and 
function of CD4+CD25+ regulatory T cells. Nat Immunol (2003) 4:330–6. 
doi:10.1038/ni904 
 180. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development 
by the transcription factor Foxp3. Science (2003) 299:1057–61. doi:10.1126/
science.1079490 
 181. Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, Beavo 
JA, et al. Foxp3-dependent programme of regulatory T-cell differentiation. 
Nature (2007) 445:771–5. doi:10.1038/nature05543 
 182. Tai X, Erman B, Alag A, Mu J, Kimura M, Katz G, et al. Foxp3 transcription 
factor is proapoptotic and lethal to developing regulatory T cells unless 
counterbalanced by cytokine survival signals. Immunity (2013) 38:1116–28. 
doi:10.1016/j.immuni.2013.02.022 
 183. Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, Chen W. A critical function 
for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ 
regulatory T cells. Nat Immunol (2008) 9:632–40. doi:10.1038/ni.1607 
 184. Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M. Smad3 
and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat 
Immunol (2008) 9:194–202. doi:10.1038/ni1549 
 185. Xu L, Kitani A, Stuelten C, McGrady G, Fuss I, Strober W. Positive and 
negative transcriptional regulation of the Foxp3 gene is mediated by access 
and binding of the Smad3 protein to enhancer I. Immunity (2010) 33:313–25. 
doi:10.1016/j.immuni.2010.09.001 
 186. Josefowicz SZ, Niec RE, Kim HY, Treuting P, Chinen T, Zheng Y, et  al. 
Extrathymically generated regulatory T cells control mucosal TH2 inflam-
mation. Nature (2012) 482:395–9. doi:10.1038/nature10772 
 187. Marie JC, Letterio JJ, Gavin M, Rudensky AY. TGF-beta1 maintains suppres-
sor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp 
Med (2005) 201:1061–7. doi:10.1084/jem.20042276 
 188. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, 
et al. Abnormal lung development and cleft palate in mice lacking TGF-beta 
3 indicates defects of epithelial-mesenchymal interaction. Nat Genet (1995) 
11:415–21. doi:10.1038/ng1295-415 
 189. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, 
Boivin GP, et  al. TGFbeta2 knockout mice have multiple developmental 
defects that are non-overlapping with other TGFbeta knockout phenotypes. 
Development (1997) 124:2659–70. 
 190. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, et al. 
Transforming growth factor-beta 3 is required for secondary palate fusion. 
Nat Genet (1995) 11:409–14. doi:10.1038/ng1295-409 
 191. Dünker N, Krieglstein K. Tgfβ2-/-Tgfβ3-/- double knockout mice display 
severe midline fusion defects and early embryonic lethality. Anat Embryol 
(Berl) (2002) 206:73–83. doi:10.1007/s00429-002-0273-6 
 192. Mu Z, Yang Z, Yu D, Zhao Z, Munger JS. TGFβ1 and TGFβ3 are partially 
redundant effectors in brain vascular morphogenesis. Mech Dev (2008) 
125:508–16. doi:10.1016/j.mod.2008.01.003 
 193. McPherron AC, Huynh TV, Lee S-J. Redundancy of myostatin and 
growth/differentiation factor 11 function. BMC Dev Biol (2009) 9:24. 
doi:10.1186/1471-213X-9-24 
 194. Do J, Fink PJ, Li L, Spolski R, Robinson J, Leonard WJ, et al. Cutting edge: 
spontaneous development of IL-17-producing gamma delta T cells in the 
thymus occurs via a TGF-beta 1-dependent mechanism. J Immunol (2010) 
184:1675–9. doi:10.4049/jimmunol.0903539 
 195. Michel M-L, Mendes-da-Cruz D, Keller AC, Lochner M, Schneider E, Dy 
M, et al. Critical role of ROR-γt in a new thymic pathway leading to IL-17-
producing invariant NKT cell differentiation. Proc Natl Acad Sci U S A (2008) 
105:19845–50. doi:10.1073/pnas.0806472105 
 196. Lee YJ, Holzapfel KL, Zhu J, Jameson SC, Hogquist KA. Steady-state pro-
duction of IL-4 modulates immunity in mouse strains and is determined by 
lineage diversity of iNKT cells. Nat Immunol (2013) 14:1146–54. doi:10.1038/
ni.2731 
 197. Monteiro M, Almeida CF, Agua-Doce A, Graca L. Induced IL-17-producing 
invariant NKT cells require activation in presence of TGF-β and IL-1β. 
J Immunol (2013) 190:805–11. doi:10.4049/jimmunol.1201010 
 198. Havenar-Daughton C, Li S, Benlagha K, Marie JC. Development and func-
tion of murine ROR t+ iNKT cells are under TGF-signaling control. Blood 
(2012) 119:3486–94. doi:10.1182/blood-2012-01-401604 
 199. Rando TA, Chang HY. Aging, rejuvenation, and epigenetic reprogram-
ming: resetting the aging clock. Cell (2012) 148:46–57. doi:10.1016/j.
cell.2012.01.003 
August 2015 | Volume 6 | Article 44215
Jurberg et al. TGF-β superfamily in the thymus
Frontiers in Immunology | www.frontiersin.org
 200. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, 
et al. Changes in thymic function with age and during the treatment of HIV 
infection. Nature (1998) 396:690–5. doi:10.1038/25374 
 201. Coelho VDM, Bunbury A, Rangel LB, Giri B, Weeraratna A, Morin PJ, 
et al. Fat-storing multilocular cells expressing CCR5 increase in the thymus 
with advancing age: potential role for CCR5 ligands on the differentiation 
and migration of preadipocytes. Int J Med Sci (2010) 7:1–14. doi:10.7150/
ijms.7.1 
 202. Müller L, Pawelec G. Aging and immunity – impact of behavioral interven-
tion. Brain Behav Immun (2014) 39:8–22. doi:10.1016/j.bbi.2013.11.015 
 203. Ventevogel MS, Sempowski GD. Thymic rejuvenation and aging. Curr Opin 
Immunol (2013) 25:516–22. doi:10.1016/j.coi.2013.06.002 
 204. Sutherland JS, Goldberg GL, Hammett MV, Uldrich AP, Berzins SP, 
Heng TS, et  al. Activation of thymic regeneration in mice and humans 
following androgen blockade. J Immunol (2005) 175:2741–53. doi:10.4049/
jimmunol.175.4.2741 
 205. Hirakata A, Okumi M, Griesemer AD, Shimizu A, Nobori S, Tena A, 
et  al. Reversal of age-related thymic involution by an LHRH agonist 
in miniature swine. Transpl Immunol (2010) 24:76–81. doi:10.1016/j.
trim.2010.08.001 
 206. Berent-Maoz B, Montecino-Rodriguez E, Signer RAJ, Dorshkind K. 
Fibroblast growth factor-7 partially reverses murine thymocyte progen-
itor aging by repression of Ink4a. Blood (2012) 119:5715–21. doi:10.1182/
blood-2011-12-400002 
 207. Min D, Panoskaltsis-Mortari A, Kuro-o M, Holländer GA, Blazar BR, 
Weinberg KI. Sustained thymopoiesis and improvement in functional 
immunity induced by exogenous KGF administration in murine models of 
aging. Blood (2007) 109:2529–37. doi:10.1182/blood-2006-08-043794 
 208. Morrhaye G, Kermani H, Legros J-J, Baron F, Beguin Y, Moutschen M, et al. 
Impact of growth hormone (GH) deficiency and GH replacement upon 
thymus function in adult patients. PLoS One (2009) 4:e5668. doi:10.1371/
journal.pone.0005668 
 209. Taub DD, Murphy WJ, Longo DL. Rejuvenation of the aging thymus: growth 
hormone-mediated and ghrelin-mediated signaling pathways. Curr Opin 
Pharmacol (2010) 10:408–24. doi:10.1016/j.coph.2010.04.015 
 210. Phillips JA, Brondstetter TI, English CA, Lee HE, Virts EL, Thoman ML. IL-7 
gene therapy in aging restores early thymopoiesis without reversing involu-
tion. J Immunol (2004) 173:4867–74. doi:10.4049/jimmunol.173.8.4867 
 211. Velardi E, Dudakov JA, Van den Brink MRM. Clinical strategies to enhance 
thymic recovery after allogeneic hematopoietic stem cell transplantation. 
Immunol Lett (2013) 155:31–5. doi:10.1016/j.imlet.2013.09.016 
 212. Zook EC, Krishack PA, Zhang S, Zeleznik-Le NJ, Firulli AB, Witte PL, et al. 
Overexpression of Foxn1 attenuates age-associated thymic involution and 
prevents the expansion of peripheral CD4 memory T cells. Blood (2011) 
118:5723–31. doi:10.1182/blood-2011-03-342097 
 213. Bredenkamp N, Nowell CS, Blackburn CC. Regeneration of the aged 
thymus by a single transcription factor. Development (2014) 141:1627–37. 
doi:10.1242/dev.103614 
 214. Bredenkamp N, Ulyanchenko S, O’Neill KE, Manley NR, Vaidya HJ, 
Blackburn CC. An organized and functional thymus generated from FOXN1-
reprogrammed fibroblasts. Nat Cell Biol (2014) 16(9):902–8. doi:10.1038/
ncb3023 
 215. Sinha M, Jang YC, Oh J, Khong D, Wu EY, Manohar R, et  al. Restoring 
systemic GDF11 levels reverses age-related dysfunction in mouse skeletal 
muscle. Science (2014) 344:649–52. doi:10.1126/science.1251152 
 216. Katsimpardi L, Litterman NK, Schein PA, Miller CM, Loffredo FS, 
Wojtkiewicz GR, et  al. Vascular and neurogenic rejuvenation of the 
aging mouse brain by young systemic factors. Science (2014) 344:630–4. 
doi:10.1126/science.1251141 
 217. Zhang Y, Shao J, Wang Z, Yang T, Liu S, Liu Y, et al. Growth differentiation fac-
tor 11 is a protective factor for osteoblastogenesis by targeting PPARgamma. 
Gene (2014) 557(2):6–11. doi:10.1016/j.gene.2014.12.039 
 218. Finkenzeller G, Stark GB, Strassburg S. Growth differentiation factor 11 
supports migration and sprouting of endothelial progenitor cells. J Surg Res 
(2015) 198(1):1–7. doi:10.1016/j.jss.2015.05.001 
 219. Suragani RNVS, Cadena SM, Cawley SM, Sako D, Mitchell D, Li R, et  al. 
Transforming growth factor-β superfamily ligand trap ACE-536 corrects 
anemia by promoting late-stage erythropoiesis. Nat Med (2014) 20:408–14. 
doi:10.1038/nm.3512 
 220. Egerman MA, Cadena SM, Gilbert JA, Meyer A, Nelson HN, Swalley SE, 
et al. GDF11 increases with age and inhibits skeletal muscle regeneration. Cell 
Metab (2015) 22(1):1–11. doi:10.1016/j.cmet.2015.05.010 
 221. Pishel I, Shytikov D, Orlova T, Peregudov A, Artyuhov I, Butenko G. 
Accelerated aging versus rejuvenation of the immune system in heterochronic 
parabiosis. Rejuvenation Res (2012) 15:239–48. doi:10.1089/rej.2012.1331 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2015 Jurberg, Vasconcelos-Fontes and Cotta-de-Almeida. This is an 
open-access article distributed under the terms of the Creative Commons Attribution 
License (CC BY). The use, distribution or reproduction in other forums is permitted, 
provided the original author(s) or licensor are credited and that the original publica-
tion in this journal is cited, in accordance with accepted academic practice. No use, 
distribution or reproduction is permitted which does not comply with these terms.
